Roberto Ferrari
#96,005
Most Influential Person Now
Researcher
Roberto Ferrari's AcademicInfluence.com Rankings
Roberto Ferraricomputer-science Degrees
Computer Science
#3310
World Rank
#3472
Historical Rank
Computational Linguistics
#144
World Rank
#148
Historical Rank
Machine Learning
#358
World Rank
#363
Historical Rank
Artificial Intelligence
#551
World Rank
#562
Historical Rank
Download Badge
Computer Science
Roberto Ferrari's Degrees
- PhD Computer Science University of Milan
- Masters Computer Engineering Polytechnic University of Milan
- Bachelors Computer Engineering Polytechnic University of Milan
Similar Degrees You Can Earn
Why Is Roberto Ferrari Influential?
(Suggest an Edit or Addition)Roberto Ferrari's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2013) (6036)
- ESC / EACTS Guidelines on myocardial revascularization (2012) (5643)
- 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. (2013) (3723)
- 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous (2014) (3302)
- Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. (2000) (2331)
- 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). (2013) (2221)
- Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). (2005) (1481)
- Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. (2005) (1207)
- Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial (2008) (1000)
- Resting heart rate in cardiovascular disease. (2007) (981)
- Short-Term Heart Rate Variability Strongly Predicts Sudden Cardiac Death in Chronic Heart Failure Patients (2003) (837)
- The 2013 ESH/ESC guidelines for the management of arterial hypertension (2013) (805)
- Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial (2008) (774)
- The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. (2004) (654)
- Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry (2012) (619)
- Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting: A Randomized Multicenter Trial (2012) (602)
- Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. (1995) (547)
- 213 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy (2013) (484)
- Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry (2017) (475)
- Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. (1980) (464)
- Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis (2016) (453)
- CD34+ and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure (2004) (412)
- European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions (2016) (399)
- Ivabradine in stable coronary artery disease without clinical heart failure. (2014) (395)
- Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. (1994) (385)
- Oxygen-mediated myocardial damage during ischaemia and reperfusion: role of the cellular defences against oxygen toxicity. (1985) (382)
- Hibernating myocardium: diagnosis and patient outcomes. (2007) (361)
- SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials (2015) (355)
- Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. (1989) (347)
- Oxidative stress during myocardial ischaemia and heart failure. (1998) (342)
- Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome. (2011) (338)
- Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study (2016) (332)
- Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. (2005) (322)
- Occurrence of oxidative stress during reperfusion of the human heart. (1990) (321)
- Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. (1993) (305)
- Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long‐Term Registry (2017) (278)
- Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. (2005) (270)
- The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. (2001) (267)
- Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. (2008) (262)
- Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha. (1999) (246)
- Pathogenesis of Congestive State in Chronic Obstructive Pulmonary Disease: Studies of Body Water and Sodium, Renal Function, Hemodynamics, and Plasma Hormones During Edema and After Recovery (1992) (242)
- Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. (1991) (242)
- European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions (2017) (241)
- Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. (2005) (229)
- The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function. (2001) (229)
- Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention: Results From the Double-Blind, Prospective, Randomized Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance (2009) (226)
- Therapeutic Effects of l‐Carnitine and Propionyl‐l‐carnitine on Cardiovascular Diseases: A Review (2004) (226)
- Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. (2009) (213)
- Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance. European Heart Failure Training Group. (1998) (210)
- Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. (2002) (205)
- Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes (2000) (200)
- The protective role of heat stress in the ischaemic and reperfused rabbit myocardium. (1992) (196)
- The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine. (1988) (195)
- Tumor Necrosis Factor-&agr; Receptor 1 Is a Major Predictor of Mortality and New-Onset Heart Failure in Patients With Acute Myocardial Infarction: The Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) Study (2005) (194)
- Oxidative stress in cardiovascular disease: myth or fact? (2003) (194)
- Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™) (2014) (190)
- Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). (2012) (190)
- Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). (2012) (185)
- The role of mitochondria in ischemic heart disease. (1996) (179)
- The role of TNF in cardiovascular disease. (1999) (178)
- COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm? (2020) (174)
- Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). (1997) (167)
- Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients wit (2012) (164)
- The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial. (2004) (162)
- Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease. (2014) (157)
- Left bundle branch block as a risk factor for progression to heart failure (2007) (156)
- Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study. (2006) (154)
- ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. (2007) (152)
- L-Carnitine and its role in medicine: from function to therapy (1992) (144)
- Myocardial recovery during post-ischaemic reperfusion: effects of nifedipine, calcium and magnesium. (1986) (143)
- Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C‐ring conformation (2017) (142)
- The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy. (2005) (137)
- Heart failure with preserved ejection fraction: uncertainties and dilemmas (2015) (136)
- Pathophysiologic and Therapeutic Importance of Tissue ACE: A Consensus Report (2002) (134)
- Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart (2006) (134)
- Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study. (2006) (133)
- Transradial coronary catheterization and intervention across the whole spectrum of Allen test results. (2014) (131)
- Effects of Serelaxin in Patients with Acute Heart Failure. (2019) (129)
- Cardiovascular Disease Prevention in Clinical Practice (2010) (125)
- Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry. (2014) (121)
- In‐hospital and 1‐year mortality associated with diabetes in patients with acute heart failure: results from the ESC‐HFA Heart Failure Long‐Term Registry (2017) (118)
- Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy. (2010) (117)
- Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY). (2013) (117)
- Endothelial function and dysfunction in heart failure. (1998) (113)
- CD 34 and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure (2004) (112)
- Myocardial damage during ischaemia and reperfusion. (1993) (109)
- Arginase pathway in human endothelial cells in pathophysiological conditions. (2004) (107)
- Left intraventricular myocardial deformation dyssynchrony identifies responders to cardiac resynchronization therapy in patients with heart failure. (2006) (107)
- The European trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA). (1998) (106)
- Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study. (2007) (105)
- Expert consensus document: A 'diamond' approach to personalized treatment of angina (2018) (105)
- Radiofrequency Ablation of Atrial Fibrillation: Is the Persistence of All Intraprocedural Targets Necessary for Long-Term Maintenance of Sinus Rhythm? (2008) (104)
- Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes (2012) (104)
- Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology (2021) (102)
- [Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]. (2004) (100)
- Metabolic Approaches to the Treatment of Ischemic Heart Disease: The Clinicians' Perspective (2002) (100)
- Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitropruss (2013) (98)
- Evaluation of phospholipid peroxidation as malondialdehyde during myocardial ischemia and reperfusion injury. (1991) (97)
- Aorta and skeletal muscle NO synthase expression in experimental heart failure. (1996) (96)
- Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study. (2007) (96)
- Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials. (2013) (96)
- Improved procedure for determining glutathione in plasma as an index of myocardial oxidative stress. (1987) (95)
- Heat stress limits infarct size in the isolated perfused rabbit heart. (1993) (94)
- Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells. (2004) (93)
- Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure. (1996) (93)
- Effect of α-tocopherol on hypoxic-perfused and reoxygenated rabbit heart muscle☆ (1978) (93)
- Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease (2012) (92)
- ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of theEuropeanSocietyofCardiology(ESC)anddevelopedincollaboration (2014) (91)
- The effects of ruthenium red on mitochondrial function during post-ischaemic reperfusion. (1982) (91)
- Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress. (2003) (89)
- Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE. (2007) (88)
- Exosome in Cardiovascular Diseases: A Complex World Full of Hope (2019) (88)
- Role of oxygen free radicals in ischemic and reperfused myocardium. (1991) (87)
- Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry (2017) (86)
- A protective effect of a mild acidosis on hypoxic heart muscle. (1977) (86)
- Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL. (2011) (86)
- Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology (2020) (85)
- Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction (2009) (85)
- Acute and Chronic Effects of Propionyl-L-Carnitine on the Hemodynamics, Exercise Capacity, and Hormones in Patients with Congestive Heart Failure (1998) (84)
- Urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion. (2002) (81)
- Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease. (2010) (81)
- Metabolic adaptation during a sequence of no-flow and low-flow ischemia. A possible trigger for hibernation. (1996) (80)
- Characteristics, treatments and 1‐year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long‐Term Registry (2018) (80)
- KATP Channel Gene Expression Is Induced by Urocortin and Mediates Its Cardioprotective Effect (2002) (77)
- Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium. (2000) (77)
- Incidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom (2005) (76)
- Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis. (2015) (75)
- Heart rate: a forgotten link in coronary artery disease? (2011) (75)
- Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia. (2016) (74)
- Myocarditis in COVID-19 patients: current problems (2021) (73)
- Effects of prolonged infusion of human alpha calcitonin gene-related peptide on hemodynamics, renal blood flow and hormone levels in congestive heart failure. (1991) (73)
- A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy. (2015) (72)
- ROS, Notch, and Wnt Signaling Pathways: Crosstalk between Three Major Regulators of Cardiovascular Biology (2014) (71)
- Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients (2020) (70)
- Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension. (2016) (69)
- Serum From Patients With Acute Coronary Syndromes Displays a Proapoptotic Effect on Human Endothelial Cells: A Possible Link to Pan-Coronary Syndromes (2003) (69)
- Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement (2020) (69)
- Heart Failure Association of the European Society of Cardiology update on sodium–glucose co‐transporter 2 inhibitors in heart failure (2020) (69)
- Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplas (2010) (68)
- Uric acid and coronary artery disease: An elusive link deserving further attention. (2016) (67)
- Metabolic disturbances during myocardial ischemia and reperfusion. (1995) (67)
- Tumor necrosis factor in CHF: a double facet cytokine. (1998) (67)
- Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients With ST-Segment–Elevation Myocardial Infarction and Multivessel Disease (2018) (67)
- Poor response to clopidogrel: current and future options for its management (2010) (66)
- Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. (2013) (66)
- Commentary: The new ESC guidelines for the diagnosis and management of chronic coronary syndromes. (2019) (66)
- An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction. (2010) (66)
- Skeletal muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy. (1998) (65)
- Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design. (2002) (65)
- Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study (2006) (64)
- Intracellular effects of myocardial ischaemia and reperfusion: role of calcium and oxygen. (1986) (64)
- Body fluid compartments, renal blood flow, and hormones at 6,000 m in normal subjects. (1993) (63)
- The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. (2009) (62)
- Tissue Factor and Coagulation Factor VII Levels During Acute Myocardial Infarction: Association With Genotype and Adverse Events (2006) (62)
- Extraction and assay of creatine phosphate, purine, and pyridine nucleotides in cardiac tissue by reversed-phase high-performance liquid chromatography. (1994) (62)
- An update on atrial fibrillation in 2014: From pathophysiology to treatment. (2016) (62)
- Pathogenesis of Edema in Constrictive Pericarditis: Studies of Body Water and Sodium, Renal Function, Hemodynamics, and Plasma Hormones Before and After Pericardiectomy (1991) (61)
- New insights on myocardial pyridine nucleotides and thiol redox state in ischemia and reperfusion damage. (2000) (61)
- Noradrenaline, atrial natriuretic peptide, bombesin and neurotensin in myocardium and blood of rats in congestive cardiac failure. (1989) (61)
- Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril (2005) (61)
- Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium? (1998) (59)
- Differences in the Effect of Angiotensin-converting Enzyme Inhibitors on the Rate of Endothelial Cell Apoptosis: In Vitro and In Vivo Studies (2007) (59)
- Heart rate reduction in coronary artery disease and heart failure (2016) (59)
- Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study). (2007) (58)
- Metabolic derangement in ischemic heart disease and its therapeutic control. (1998) (58)
- 17β-Estradiol Enhances Signalling Mediated by VEGF-A-Delta-Like Ligand 4-Notch1 Axis in Human Endothelial Cells (2013) (58)
- Grip strength predicts cardiac adverse events in patients with cardiac disorders: an individual patient pooled meta-analysis (2018) (57)
- Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry (2019) (57)
- Efficacy of Ivabradine in Combination with Beta-Blocker Versus Uptitration of Beta-Blocker in Patients with Stable Angina (2011) (57)
- Pulmonary haemodynamics of the yak, cattle, and cross breeds at high altitude. (1986) (57)
- The BEAUTIFUL Study: Randomized Trial of Ivabradine in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction – Baseline Characteristics of the Study Population (2007) (56)
- Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registry (2015) (56)
- Role of A2A receptor in the modulation of myocardial reperfusion damage. (1999) (55)
- Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia). (2014) (53)
- Cardiac resynchronization therapy guided by multimodality cardiac imaging (2016) (53)
- Occurrence of oxidative stress during myocardial reperfusion (1992) (53)
- Genetic determinants of on-clopidogrel high platelet reactivity (2011) (53)
- The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial. (2007) (52)
- Metabolic changes during post-ischaemic reperfusion. (1988) (52)
- Insight into the Mode of Action of ACE Inhibition in Coronary Artery Disease (2012) (51)
- Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response (2006) (51)
- Chromogranin A and Tumor Necrosis Factor-α (TNF) in Chronic Heart Failure (2002) (51)
- Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling. (2011) (51)
- Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis (2016) (50)
- Long‐term treatment with ivabradine in post‐myocardial infarcted rats counteracts f‐channel overexpression (2012) (50)
- Protection of the Ischemic Myocardium by the Converting-Enzyme Inhibitor Zofenopril: Insight Into Its Mechanism of Action (1992) (50)
- Oxygen free radicals and reperfusion injury; the effect of ischaemia and reperfusion on the cellular ability to neutralise oxygen toxicity. (1986) (50)
- Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats. (2001) (50)
- Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial (2007) (50)
- Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction. (2004) (49)
- Release of atrial natriuretic peptide-like immunoreactive material during stretching of the rat atrium in vitro. (1987) (49)
- Echocardiographic myocardial scar burden predicts response to cardiac resynchronization therapy in ischemic heart failure. (2009) (48)
- The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome. (2020) (48)
- Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk. (2006) (48)
- ACE Inhibition and Endothelial Function: Main Findings of PERFECT, a Sub-Study of the EUROPA Trial (2007) (48)
- Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease (2017) (47)
- Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). (2012) (47)
- Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post‐Hoc Analysis of the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) Trial (2017) (47)
- β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study (2019) (47)
- The 5-year clinical outcomes after a randomized comparison of sirolimus-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction. (2009) (47)
- The Notch pathway: a crossroad between the life and death of the endothelium. (2013) (47)
- The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease. (2014) (47)
- A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals (2011) (47)
- Reperfusion Damage - A Story of Success, Failure, and Hope. (2017) (46)
- Fractional Flow Reserve Evaluation and Chronic Kidney Disease: Analysis From a Multicenter Italian Registry (the FREAK Study) (2016) (46)
- Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium (2010) (46)
- Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry (2019) (46)
- The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review (2013) (46)
- Current views on anthracycline cardiotoxicity (2016) (45)
- Major differences among the three classes of calcium antagonists. (1997) (45)
- Changes in the cardiac glutathione status after ischemia and reperfusion (1985) (44)
- Treatment of heart failure with diuretics: body compartments, renal function and plasma hormones. (1989) (44)
- New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma (2018) (44)
- Biochemical analysis of muscle biopsy in overnight fasting patients with severe chronic heart failure. (1996) (44)
- Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study. (2015) (44)
- The metabolical effects of L-carnitine in angina pectoris. (1984) (44)
- Therapeutic modulation of the nitric oxide: all ace inhibitors are not equivalent. (2007) (44)
- Early and Late Effects of Leukopenic Reperfusion on the Recovery of Cardiac Contractile Function Studies in the Transplanted and Isolated Blood‐Perfused Rat Heart (1993) (44)
- Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha. (1999) (44)
- The Notch pathway: a novel target for myocardial remodelling therapy? (2014) (43)
- Anti-ischaemic effect of ivabradine. (2006) (43)
- Role of skeletal muscle in the syndrome of chronic heart failure. (1996) (43)
- Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart. (2009) (43)
- The occurrence of oxidative stress during reperfusion in experimental animals and men (1991) (43)
- Hibernating myocardium: another piece of the puzzle falls into place. (2006) (43)
- Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis (2016) (43)
- Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and Hypertension (2018) (42)
- Anti-anginal drugs–beliefs and evidence: systematic review covering 50 years of medical treatment (2018) (42)
- Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability. (2000) (42)
- Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA study. (2010) (42)
- Impact of tissue harmonic imaging in patients with distorted left ventricles: improvement in accuracy and reproducibility of visual, manual and automated echocardiographic assessment of left ventricular ejection fraction. (2003) (42)
- The neuroendocrine and sympathetic nervous system in congestive heart failure. (1998) (42)
- Treatment of Angina: Where Are We? (2018) (42)
- Oxygen-free radicals at myocardial level: effects of ischaemia and reperfusion. (1994) (42)
- Myocardial hibernation and stunning: from physiological principles to clinical practice (1998) (41)
- Estrogen receptor β–dependent Notch1 activation protects vascular endothelium against tumor necrosis factor α (TNFα)-induced apoptosis (2017) (41)
- Intracardiac Flow Analysis: Techniques and Potential Clinical Applications (2019) (41)
- Trimetazidine in cardiovascular medicine. (2019) (41)
- Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events, and Bleeding in Stable Coronary Artery Disease. (2017) (40)
- Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease (2017) (40)
- Prognostic benefits of heart rate reduction in cardiovascular disease (2003) (40)
- The propionyl-L-carnitine hypothesis: an alternative approach to treating heart failure. (1997) (39)
- Importance of sympathetic activation for the expression of Na+-Ca2+ exchanger in end-stage failing human myocardium. (2002) (39)
- Effect of L-carnitine derivatives on heart mitochondrial damage induced by lipid peroxidation. (1988) (38)
- ACE Inhibition Modulates Endothelial Apoptosis and Renewal via Endothelial Progenitor Cells in Patients with Acute Coronary Syndromes (2011) (38)
- The Role of Notch in the Cardiovascular System: Potential Adverse Effects of Investigational Notch Inhibitors (2015) (38)
- Left ventricular ejection fraction and heart failure: an indissoluble marriage? (2018) (37)
- Effects of iloprost (ZK 36374) on glutathione status during ischaemia and reperfusion of rabbit isolated hearts (1989) (37)
- Three-year follow-up of the MULTIcentre evaluation of Single high-dose Bolus TiRofiban versus Abciximab with Sirolimus-eluting STEnt or Bare-Metal Stent in Acute Myocardial Infarction StudY (MULTISTRATEGY). (2013) (37)
- Prolonged protective effect of propranolol on hypoxic heart muscle. (1978) (37)
- Oxidative stress during myocardial ischaemia and reperfusion: Experimental and clinical evidence (1986) (37)
- Mechanisms of Remodelling (2009) (36)
- Cardioprotection by nisoldipine: role of timing of administration. (1993) (36)
- Abnormalities of left ventricular function in asymptomatic patients with systemic sclerosis using Doppler measures of myocardial strain. (2008) (36)
- Plasma hormone levels and haemodynamics in patients with chronic obstructive lung disease. (1996) (36)
- Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction. (2004) (35)
- Hypertension, aging, and myocardial synthesis of heat-shock protein 72. (1994) (35)
- ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: Pertinent (2007) (35)
- Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants: Effects on Survival in Myocardial Infarction Patients (2007) (35)
- "Myocardial stunning" remaining questions. (1998) (35)
- Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy). (2011) (34)
- White coats and fingerprints: diagnostic reasoning in medicine and investigative methods of fictional detectives (2005) (34)
- Specific properties and effect of perindopril in controlling the renin-angiotensin system. (2005) (34)
- Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry (2016) (33)
- Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction. (2018) (33)
- Atrial natriuretic peptide: its mechanism of release from the atrium. (1989) (33)
- Metalloproteinase 2 cleaves in vitro recombinant TRAIL: potential implications for the decreased serum levels of TRAIL after acute myocardial infarction. (2010) (33)
- Cardiovascular and hormonal effects of calcitonin gene-related peptide in congestive heart failure. (1991) (32)
- Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease (2009) (32)
- Mechanisms of remodelling: a question of life (stem cell production) and death (myocyte apoptosis). (2009) (32)
- Occurrence and impact of chronic obstructive pulmonary disease in elderly patients with stable heart failure (2013) (32)
- Different Image Integration Modalities to Guide AF Ablation: Impact on Procedural and Fluoroscopy Times (2011) (32)
- Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease. (2019) (32)
- Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion. (1990) (32)
- Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology (2016) (31)
- Skeletal muscle function at low work level as a model for daily activities in patients with chronic heart failure. (1997) (31)
- Development and validation of a cardiovascular risk assessment model in patients with established coronary artery disease. (2013) (31)
- Secondary Prevention of Coronary Disease with ACE Inhibition-does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA? (2009) (30)
- Time course of endothelial dysfunction markers and mortality in COVID‐19 patients: A pilot study (2021) (30)
- Vitamin E and the heart: possible role as antioxidant. (1983) (30)
- Mitochondrial energy production and cation control in myocardial ischaemia and reperfusion (1993) (30)
- Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease (2004) (30)
- Circulating stem cell vary with NYHA stage in heart failure patients (2011) (30)
- Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial (2020) (30)
- Cellular thiols redox status: a switch for NF-kappaB activation during myocardial post-ischaemic reperfusion. (2002) (30)
- In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome (2013) (29)
- Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry. (2014) (29)
- 'Myocardial hibernation'--questions and controversies. (1997) (29)
- Prolonged propionyl-L-carnitine pre-treatment of rabbit: biochemical, hemodynamic and electrophysiological effects on myocardium. (1991) (29)
- Oxygen Free Radical‐Mediated Heart Injury in Animal Models and during Bypass Surgery in Humans Effects of α‐Tocopherol a (1989) (29)
- Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R). Rationale for the Study and Protocol Design (2008) (29)
- Stunned and Hibernating Myocardium: Possibility of Intervention (1992) (29)
- Plasma CGRP-like immunoreactivity in treated and untreated congestive heart failure (1991) (29)
- Novel role of the nutraceutical bioactive compound berberine in lectin-like OxLDL receptor 1-mediated endothelial dysfunction in comparison to lovastatin. (2017) (29)
- Remote monitoring of implantable devices: Should we continue to ignore it? (2016) (28)
- The Notch pathway: a novel therapeutic target for cardiovascular diseases? (2019) (28)
- Alterations of Glutathione Status during Myocardial Ischaemia and Reperfusion (1988) (28)
- On-treatment platelet reactivity in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention (2013) (28)
- Efficacy of perindopril in reducing risk of cardiac events in patients with revascularized coronary artery disease. (2007) (28)
- The role of Notch pathway in cardiovascular diseases (2013) (28)
- Commentary: What is the relationship between Covid-19 and cardiovascular disease? (2020) (28)
- Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction. (2012) (28)
- Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure (2020) (27)
- EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT). (2016) (27)
- Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? (2015) (27)
- Comparison of myocardial deformation and velocity dyssynchrony for identification of responders to cardiac resynchronization therapy (2009) (27)
- Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery (2013) (27)
- Cancer therapy-induced cardiotoxicity: role of ultrasound deformation imaging as an aid to early diagnosis. (2015) (27)
- Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure. (2003) (26)
- Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study. (2015) (26)
- Atrial Fibrillation and Recurrent Ventricular Fibrillation During Hypokalemia in Brugada Syndrome (2005) (26)
- Calcium channel blockers and ischaemic heart disease: theoretical expectations and clinical experience. (1991) (26)
- The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease (2009) (26)
- Protective effect of a prostacyclin-mimetic on the ischaemic-reperfused rabbit myocardium. (1988) (26)
- How do calcium antagonists differ in clinical practice? (1994) (26)
- Heart, lung, and vascular registries: Evolving goals, successful approaches, and ongoing innovation. (2016) (25)
- RAAS inhibition and mortality in hypertension (2013) (24)
- Nutritional status and all-cause mortality in older adults with acute coronary syndrome. (2020) (24)
- Reperfusion Injury: Does It Exist and Does It Have Clinical Relevance? (2004) (24)
- Effects of endotoxic shock on neuronal NOS and calcium transients in rat cardiac myocytes. (2005) (24)
- Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings. (2016) (24)
- Coagulation factors and recurrence of ischemic and bleeding adverse events in patients with acute coronary syndromes. (2013) (24)
- Left ventricular dysfunction due to the new ischemic outcomes: stunning and hibernation. (1996) (24)
- Pacing transmural scar tissue reduces left ventricle reverse remodeling after cardiac resynchronization therapy. (2013) (24)
- Thrombin generation assay: a new tool to predict and optimize clinical outcome in cardiovascular patients? (2012) (24)
- Impact of Chronic Kidney Disease on Use of Evidence-Based Therapy in Stable Coronary Artery Disease: A Prospective Analysis of 22,272 Patients (2014) (24)
- Chromogranin A and tumor necrosis factor-alpha (TNF) in chronic heart failure. (2000) (24)
- ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT study. (2009) (24)
- Extracorporeal Circulatory Support in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis (2017) (24)
- Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: a pilot study (2017) (23)
- The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials (2017) (23)
- Ticagrelor Improves Endothelial Function by Decreasing Circulating Epidermal Growth Factor (EGF) (2018) (23)
- Myocardial Ischemia and Lipid Metabolism (2012) (23)
- KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction (2019) (23)
- Role of bradykinin and eNOS in the anti‐ischaemic effect of trandolapril (2001) (23)
- Enalapril as initial and sole treatment in severe chronic heart failure with sodium retention. (1990) (22)
- PERTINENT—PERindopril–Thrombosis, InflammatioN, Endothelial Dysfunction and Neurohormonal Activation Trial: A Sub-Study of the EUROPA Study (2004) (22)
- The battle against COVID-19: mortality in Italy (2020) (22)
- Effects of perindopril on cardiac remodelling and prognostic value of pre-discharge quantitative echocardiographic parameters in elderly patients after acute myocardial infarction: the PREAMI echo sub-study. (2009) (22)
- Beneficial effects of propionyl L-carnitine on sarcolemmal changes in congestive heart failure due to myocardial infarction. (1999) (22)
- Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): rationale and design of a randomized clinical trial (2018) (22)
- Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients (2021) (22)
- Heart failure: an historical perspective (2016) (22)
- TNF-α modulates the migratory response of mesenchymal stem cells to TRAIL (2010) (22)
- Pro-inflammatory genetic profile and familiarity of acute myocardial infarction (2012) (22)
- Skeletal muscle metabolism in experimental heart failure. (1996) (22)
- Superoxide dismutase: possible therapeutic use in cardiovascular disease. (1989) (21)
- Echocardiographic Evaluation of Left Ventricular Output in Patients with Heart Failure: A Per-Beat or Per-Minute Approach? (2019) (21)
- Effect of angiotensin converting enzyme inhibition with quinaprilat on the ischaemic and reperfused myocardium. (1994) (21)
- The Investigators of the Study on Propionyl-L-Carnitine in Chronic Heart Failure (1999) (21)
- Gene-gene and gene - clinical factors interaction in acute myocardial infarction: a new detailed risk chart. (2010) (21)
- Protective effect of propionyl-L-carnitine against ischaemia and reperfusion-damage (2004) (21)
- PEG-SOD and myocardial antioxidant status during ischaemia and reperfusion: dose-response studies in the isolated blood perfused rabbit heart. (1992) (21)
- A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the ESC‐HFA EORP Heart Failure Long‐Term Registry (2021) (21)
- Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function. (2007) (20)
- Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry (2018) (20)
- Neurohormonal modulation in chronic heart failure (2002) (20)
- Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunction. (2015) (20)
- Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis. (2015) (20)
- The in vitro effects of verbascoside on human platelet aggregation (2012) (20)
- A step further with ivabradine: SIGNIfY (Study assessInG the morbidity–mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease) (2009) (20)
- Specific and selective If inhibition : expected clinical benefits from pure heart rate reduction in coronary patients (2005) (20)
- The carnitine system : a new therapeutical approach to cardiovascular diseases (1995) (20)
- Continuous versus intermittent warm blood cardioplegia: functional and energetics changes. (1996) (20)
- Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome (2017) (20)
- Effect of ACE inhibition on myocardial ischaemia. (1998) (20)
- Coronary artery anomalies presenting with ST-segment elevation myocardial infarction (2011) (20)
- From left ventricular ejection fraction to cardiac hemodynamics: role of echocardiography in evaluating patients with heart failure (2019) (20)
- The blood perfused isolated heart: characterization of the model (1999) (20)
- Full Sternotomy, Hemisternotomy, and Minithoracotomy for Aortic Valve Surgery: Is There a Difference? (2018) (20)
- Right heart failure chronically stimulates heat shock protein 72 in heart and liver but not in other tissues. (1996) (20)
- Effects of verapamil and nifedipine on rate of left ventricular relaxation in coronary arterial disease patients. (1987) (19)
- Temporal relations of the endocrine response to exercise. (1991) (19)
- Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-Cardiac Surgery (2010) (19)
- Hibernating myocardium: Its pathophysiology and clinical role (1998) (19)
- Effects of some L-carnitine derivatives on heart membrane ATPases (1991) (19)
- Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent (2012) (19)
- Myocardial xanthine oxidoreductase activity in hypertensive and hypercholesterolemic rats. (1992) (19)
- Importance of free radicals generated by endothelial and myocardial cells in ischemia and reperfusion (1990) (19)
- The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study (2017) (19)
- Changes in oxidative stress and cellular redox potential during myocardial storage for transplantation: experimental studies. (1999) (19)
- Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials. (2017) (19)
- Heart rate reduction with ivabradine in the early phase of atherosclerosis is protective in the endothelium of ApoE-deficient mice. (2018) (19)
- Intermittent v continuous ischemia decelerates adenylate breakdown and prevents norepinephrine release in reperfused rabbit heart. (1995) (18)
- Impairment of mitophagy and autophagy accompanies calcific aortic valve stenosis favoring cell death and the severity of disease. (2021) (18)
- Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function? (2006) (18)
- Sedation with Midazolam for Electrical Cardioversion (2007) (18)
- The pulmonary circulation of some domestic animals at high altitude (1988) (18)
- Anti-anginal drugs: Systematic review and clinical implications. (2019) (18)
- The role of heart rate may differ according to pathophysiological setting: from SHIFT to SIGNIFY. (2015) (18)
- ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic–therapeutic pathway in Italy (2017) (18)
- Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventric (2006) (18)
- Effect of alpha-tocopherol on hypoxic-perfused and reoxygenated rabbit heart muscle. (1978) (18)
- Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial. (2007) (18)
- Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19 (2021) (18)
- Implantable cardioverter defibrillators: from evidence of trials to clinical practice (2007) (18)
- Diuretics as initial and sole treatment in chronic cardiac failure. (1991) (17)
- Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history. (2016) (17)
- Activation of ANP synthesis during congestive heart failure in rats treated with monocrotaline. (1995) (17)
- Optimizing the treatment of hypertension and stable coronary artery disease: clinical evidence for fixed-combination perindopril/amlodipine (2008) (17)
- Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trial (2007) (17)
- Living alone and cardiovascular disease outcomes (2019) (17)
- Selective and specific If inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease (2011) (17)
- High-dose heparin impairs nitric oxide pathway and vasomotion in rats. (1999) (17)
- Ivabradine: Heart Rate and Left Ventricular Function (2014) (17)
- Metabolic and functional consequences of successive no-flow and sustained low-flow ischaemia; a 31P MRS study in rat hearts. (1996) (17)
- The Mediterranean diet: a cultural journey (2011) (17)
- Differential Role of Circulating microRNAs to Track Progression and Pre-Symptomatic Stage of Chronic Heart Failure: A Pilot Study (2020) (17)
- Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease (2020) (17)
- Neuroendocrine response to standing and mild exercise in patients with untreated severe congestive heart failure and chronic constrictive pericarditis. (1996) (17)
- The heart rate story (2011) (17)
- Species-specific modulation of the nitric oxide pathway after acute experimentally induced endotoxemia (2003) (17)
- Plasma levels of atrial natriuretic factor (ANF) and urinary excretion of ANF, arginine vasopressin and catecholamines in children with congenital heart disease: effect of cardiac surgery. (1993) (17)
- Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). (2012) (17)
- Hemodynamic, hormonal, and renal effects of atrial natriuretic peptide in untreated congestive cardiac failure. (1989) (17)
- Stretch-induced centrifugal movement of atrial specific granules--a preparatory step in atrial natriuretic peptide secretion. (1989) (16)
- Evaluation of platelet inhibition by tirofiban in patients stratified according to aspirin and clopidogrel responsiveness: the 3T/2R (Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel). (2010) (16)
- Heat shock protein changes in hibernation: a similarity with heart failure? (1996) (16)
- Demographic and clinical characteristics of patients with stable coronary artery disease: results from the CLARIFY registry in Spain. (2014) (16)
- Polar plot maps by parametric strain echocardiography allow accurate evaluation of non-viable transmural scar tissue in ischaemic heart disease. (2016) (16)
- Dichotomy in the post-ischemic metabolic and functional recovery profiles of isolated blood-versus buffer-perfused heart. (1996) (16)
- Acute heart failure: lessons learned, roads ahead (2018) (16)
- Angiotensin converting enzyme inhibitor–calcium antagonist combination: an alliance for cardioprotection? (1997) (16)
- Pulmonary endocrine cells in various species in the Himalaya. (1988) (16)
- Improvement of cardiac function and &bgr;-adrenergic signal transduction by propionyl L-carnitine in congestive heart failure due to myocardial infarction (2004) (16)
- Not just numbers, but years of science: putting the ACE inhibitor-ARB meta-analyses into context. (2013) (16)
- Prognostic value of serial platelet reactivity measurements on long‐term clinical outcome in patients with ST‐elevation myocardial infarction undergoing primary PCI (2008) (16)
- Relationship between physical activity and long-term outcomes in patients with stable coronary artery disease (2020) (16)
- Factors influencing the metabolic and functional alterations induced by ischaemia and riperfusion (1983) (16)
- Revascularization of hibernating myocardium: rate of metabolic and functional recovery and occurrence of oxidative stress. (2002) (16)
- Lipid peroxidation during myocardial reperfusion (1992) (16)
- The role of mitochondrial function in the ischemic and reperfused myocardium (1982) (16)
- Skeletal muscle abnormalities in rats with experimentally induced heart hypertrophy and failure (2003) (16)
- Left Ventricular Lead Position Guided by Parametric Strain Echocardiography Improves Response to Cardiac Resynchronization Therapy (2017) (16)
- PEG-SOD improves postischemic functional recovery and antioxidant status in blood-perfused rabbit hearts. (1992) (15)
- Effect of lipid peroxidation on heart mitochondria oxygen consuming and calcium transporting capacities (1988) (15)
- Quality of Life With Ivabradine in Patients With Angina Pectoris: The Study Assessing the Morbidity–Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life Substudy (2016) (15)
- Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison (2016) (15)
- Angiotensin II overproduction: enemy of the vessel wall (2002) (15)
- Effect of propionyl-L-carnitine on experimental induced cardiomyopathy in rats. (1992) (15)
- Management of outpatients in France with stable coronary artery disease. Findings from the prospeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease (CLARIFY) registry. (2014) (15)
- Catecholamines: the cardiovascular and neuroendocrine system. (1998) (15)
- High-Dose BoluS TiRofibAn and Sirolimus Eluting STEnt versus Abiciximab and Bare Metal Stent in Acute MYocardial Infarction (STRATEGY) Study—Protocol Design and Demography of the First 100 Patients (2004) (15)
- Novel Echocardiographic Approach to Hemodynamic Phenotypes Predicts Outcome of Patients Hospitalized With Heart Failure (2020) (15)
- Importance of oxygen free radicals during ischemia and reperfusion in the experimental and clinical setting. Oxygen free radicals and the heart. (1992) (15)
- Randomized, double‐blind comparison of effects of abiciximab bolus only vs. on‐label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting (2010) (15)
- Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease (2010) (15)
- Effect of propionyl-L-carnitine on mechanical function of isolated rabbit heart (1991) (15)
- Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry (2015) (15)
- The role of allopurinol in preventing oxygen free radical injury to skeletal muscle and endothelial cells after ischemia-reperfusion. (1996) (15)
- The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria (1991) (14)
- Hormonal response in untreated myocardial infarction. (1990) (14)
- The importance of cachexia in the syndrome of heart failure. (1997) (14)
- Left ventricular dysfunction due to stunning and hibernation in patients (1994) (14)
- Limb salvage in diabetic patients with no-option critical limb ischemia: outcomes of a specialized center experience (2019) (14)
- Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry. (2021) (14)
- Isoproterenol induces release of atrial natriuretic peptide from rat atrium in vitro. (1992) (14)
- Relevance of apoptosis in influencing recovery of hibernating myocardium (2007) (14)
- A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients. (2021) (14)
- Ischemic preconditioning, myocardial stunning, and hibernation: basic aspects. (1999) (14)
- Effects of calcium entry blockers not connected with calcium channels inhibition. (1987) (13)
- Interleukin-6: a neurohumoral predictor of prognosis in patients with heart failure: light and shadow. (2002) (13)
- Molecular Events Occurring During Post-Ischaemic Reperfusion (1987) (13)
- Tumor necrosis factor alpha in heart failure (1995) (13)
- Preserving bradykinin or blocking angiotensin II: the cardiovascular dilemma (2004) (13)
- Optimizing the treatment of hypertension and stable coronary artery disease: clinical evidence for fixed-combination perindopril/amlodipine. (2008) (13)
- Lipid peroxidation in normal pregnancy and preeclampsia. (1994) (13)
- Relation between energy metabolism, glycolysis, noradrenaline release and duration of ischemia (1996) (13)
- Immunoreactivity to various peptides in the human carotid body. (1988) (13)
- Alteration of Notch signaling and functionality of adipose tissue derived mesenchymal stem cells in heart failure. (2014) (13)
- INCREASED HEART RATE IS DETRIMENTAL : THE MYOCARDIAL METABOLIC THEORY (1999) (13)
- In Vivo Tracking of Murine Adipose Tissue-Derived Multipotent Adult Stem Cells and Ex Vivo Cross-Validation (2013) (13)
- Prognosis of patients with unstable angina or acute myocardial infarction treated with calcium channel antagonists. (1996) (13)
- Working Group on Cellular Biology of the Heart (1996) (13)
- Role of oxygen in myocardial ischaemic and reperfusion damage: effect of alpha-tocopherol. (1985) (13)
- Aortic Valve Stenosis and Mitochondrial Dysfunctions: Clinical and Molecular Perspectives (2020) (13)
- Current role of echocardiography in cardiac resynchronization therapy (2017) (13)
- Enhanced stent visualization systems during PCI: A case series and review of literature. (2015) (12)
- Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model (2016) (12)
- Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach (2019) (12)
- Antioxidant protection against damage during cardiac ischemia and reperfusion: effect of dimercapto-propanol. (1990) (12)
- Appropriateness of Prescriptions of Recommended Treatments in Organisation for Economic Co-operation and Development Health Systems: Findings Based on the Long-Term Registry of the European Society of Cardiology on Heart Failure. (2015) (12)
- Healthy versus sick myocytes: metabolism, structure and function (2002) (12)
- Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention (2017) (12)
- Improved detection of left ventricular thrombi and spontaneous echocontrast by tissue harmonic imaging in patients with myocardial infarction. (2006) (12)
- Assessment of left ventricular volume and function by integration of simplified 3D echocardiography, tissue harmonic imaging and automated extraction of endocardial borders (2004) (12)
- Impact of a recent hospitalization on treatment and prognosis of ST-segment elevation myocardial infarction. (2013) (12)
- Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape (2021) (12)
- Percutaneous Coronary Interventions (PCI) (2010) (12)
- Reversibility of Left Ventricle Longitudinal Strain Alterations Induced by Adjuvant Therapy in Early Breast Cancer Patients. (2016) (12)
- Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol (2009) (12)
- Heart rate reduction by pharmacological If current inhibition. (2006) (11)
- Experimental ischemic cardiomyopathy: insights into remodeling, physiological adaptation, and humoral response. (2006) (11)
- Can We Improve Myocardial Protection during Ischaemic Injury? (2016) (11)
- Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients. (2018) (11)
- Calcium antagonists and left ventricular dysfunction. (1995) (11)
- A randomized, double‐blind, placebo‐controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics (2019) (11)
- The chronic ischaemic cardiovascular disease ESC Pilot Registry: Results of the six-month follow-up (2018) (11)
- The role of free radicals in ischaemic myocardium (1990) (11)
- PREAMI: Perindopril and remodelling in elderly with acute myocardial infarction: Study rationale and design (2000) (11)
- In Vitro Endothelial Cell Proliferation Assay Reveals Distinct Levels of Proangiogenic Cytokines Characterizing Sera of Healthy Subjects and of Patients with Heart Failure (2014) (11)
- Inhibitory effect of acute and chronic administration of digitalis on the sick sinus node. (1986) (11)
- Prolonged protective effect of the calcium antagonist anipamil on the ischemic reperfused rabbit myocardium: Comparison with verapamil (1989) (11)
- A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial (2017) (11)
- Temporal relations of the endocrine response to hypotension with sodium nitroprusside. (1992) (11)
- TNFα in patients with congestive heart failure (2003) (11)
- Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management (2001) (11)
- WHOLE-BODY HEAT-STRESS PROTECTS THE ISOLATED PERFUSED RABBIT HEART (1990) (11)
- Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease. (2020) (11)
- Oxidative stress during myocardial ischaemia and heart failure. (1998) (10)
- Time course of human atrial natriuretic factor release during cardiopulmonary bypass in mitral valve and coronary artery diseased patients. (1991) (10)
- Effect of nolomirole on monocrotaline-induced heart failure. (2004) (10)
- Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents. (2015) (10)
- Effect of congestive heart failure on rate of atrial natriuretic factor release in response to stretch and isoprenaline. (1990) (10)
- Immune activation in severe heart failure Does etiology play a role (2004) (10)
- Importance of early recanalization of the occluded coronary artery in acute myocardial infarction for preservation of left ventricular function. (1988) (10)
- Effects of Lercanidipine and Its Enantiomers on Ischemia and Reperfusion (1997) (10)
- Pulmonary peptides, norepinephrine and endocrine cells in monocrotaline pulmonary hypertension. (1991) (10)
- The Notch pathway: a new therapeutic target in atherosclerosis? (2015) (10)
- Incident heart failure in outpatients with chronic coronary syndrome: results from the international prospective CLARIFY registry (2020) (10)
- Clinical presentation and management of stable coronary artery disease: insights from the international prospective CLARIFY registry - results from the Greek national cohort. (2014) (10)
- Effectiveness of a Novel Nutraceutical Compound Containing Red Yeast Rice, Polymethoxyflavones and Antioxidants in the Modulation of Cholesterol Levels in Subjects With Hypercholesterolemia and Low-Moderate Cardiovascular Risk: The NIRVANA Study (2019) (10)
- Effect of prolonged treatment with propionyl-L-carnitine on erucic acid-induced myocardial dysfunction in rats (1992) (10)
- Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapy (2008) (10)
- Effects of chronic noradrenaline on the nitric oxide pathway in human endothelial cells (1998) (10)
- Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease (1996) (10)
- The dynamic balance between heart function and immune activation. (1998) (9)
- 2019 CORONAVIRUS: What are the implications for cardiology? (2020) (9)
- International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina (2021) (9)
- Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: a subgroup analysis of the EUROPA trial. (2009) (9)
- CHA2DS2‐VASc score predicts atrial fibrillation recurrence after cardioversion: Systematic review and individual patient pooled meta‐analysis (2019) (9)
- Radiofrequency atrial fibrillation ablation based on pathophysiology: a diversified protocol with long-term follow-up (2008) (9)
- Importance of calcium ions in the development of ischaemic and reperfusion damage: Possibilities of interventions (1984) (9)
- Activation of the neuroendocrine response in heart failure: Adaptive or maladaptive process? (1996) (9)
- Acute haemodynamic effects of IL-6 treatment in vivo: involvement of vagus nerve in NO-mediated negative inotropism. (2005) (9)
- ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11: 3 (189-98)) (2012) (9)
- Treatment of acute decompensated heart failure with the soluble guanylate cyclase activator cinaciguat: The COMPOSE program – three randomized, controlled, phase IIb studies (2011) (9)
- Effect of D-600 on ischemic and reperfused rabbit myocardium: relation with timing and modality of administration (1989) (9)
- Long‐term outcome after percutaneous coronary intervention in patients with essential thrombocythemia (2009) (9)
- Two-year outcomes after first- or second-generation drug-eluting stent implantation in patients with in-stent restenosis. A PRODIGY trial substudy. (2014) (9)
- Residual cardiovascular risk. (2016) (9)
- Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction (2008) (9)
- Reincarnated medicines: using out-dated drugs for novel indications. (2016) (9)
- Echocardiographic evaluation of cardiac dyssynchrony: Does it still matter? (2018) (8)
- Understanding the results of the PARAGON‐HF trial (2020) (8)
- Feasibility of the transseptal approach for fast and unstable left ventricular tachycardia mapping and ablation with a non-contact mapping system (2006) (8)
- How european cardiologists perceive the role of calcium antagonists in the treatment of unstable angina. (1997) (8)
- Standard ECG in Brugada Syndrome as a Marker of Prognosis: From Risk Stratification to Pathophysiological Insights (2021) (8)
- Neuroendocrine activation in left ventricular dysfunction. (1998) (8)
- Chronic Kidney Disease Has a Graded Association with Death and Cardiovascular Outcomes in Stable Coronary Artery Disease: An Analysis of 21,911 Patients from the CLARIFY Registry (2019) (8)
- Preliminary observations on the effects of acute infusion of growth hormone on coronary vasculature and on myocardial function and energetics of an isolated and blood-perfused heart (2003) (8)
- Contact versus Noncontact Mapping for Ablation of Ventricular Tachycardia in Patients with Previous Myocardial Infarction (2009) (8)
- Editorial: heart rate (2003) (8)
- The New ESC Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes: the Good and the Not So Good. (2020) (8)
- Noncontact Mapping of Left Ventricle during CRT Implant (2010) (8)
- Priorities for Cath labs in the COVID-19 tsunami (2020) (8)
- Stunning: Damaging or protective to the myocardium? (1991) (8)
- Radiofrequency ablation of paroxysmal atrial fibrillation by mesh catheter (2009) (8)
- Metabolic modulation and optimization of energy consumption in heart failure. (2003) (8)
- Erratum: Intermittent v continuous ischemia decelerates adenylate breakdown and prevents norepinephrine release in reperfused rabbit heart (Journal of Molecular and Cellular Cardiology (1995) 27 (659-671)) (1995) (8)
- Coronary artery disease in 2012: Revising common beliefs in the management of stable CAD (2013) (8)
- Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - results from EUROPA. (2015) (8)
- Myocardial mitochondrial functions in alpha-tocopherol-deficient and -refed rabbits. (1982) (8)
- Role of ivabradine in management of stable angina in patients with different clinical profiles (2018) (8)
- Myocardial metabolism during intracoronary thrombolysis. Two illustrative cases. (1987) (8)
- ARNIs: balancing “the good and the bad” of neuroendocrine response to HF (2019) (7)
- Heat shock protein 72 in cardiac and skeletal muscles during hypertension (1995) (7)
- 842-3 Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anemia in patients with chronic heart failure (2004) (7)
- Speckle Tracking Echocardiography in Non-ST-Segment Elevation Acute Coronary Syndromes. (2019) (7)
- The revival of heart rate. (1999) (7)
- COX-2 Is Downregulated in Human Stenotic Aortic Valves and Its Inhibition Promotes Dystrophic Calcification (2020) (7)
- Edema of Cardiac Origin (2005) (7)
- Right Atrial Pressure Is Associated with Outcomes in Patients with Heart Failure and Indeterminate Left Ventricular Filling Pressure. (2020) (7)
- Remodelling after an Infarct: Crosstalk between Life and Death (2016) (7)
- Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention (2012) (7)
- RAAS inhibition and mortality in hypertension: from pharmacology to clinical evidence. (2013) (7)
- Neurohormones, Cytokines and Programmed Cell Death in Heart Failure: A New Paradigm for the Remodeling Heart (2001) (7)
- Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: analysis of the CLARIFY registry. (2015) (7)
- In vitro administration of ergothioneine failed to protect isolated ischaemic and reperfused rabbit heart. (1995) (7)
- Paroxysmal Atrial Fibrillation Ablation with the Multipolar Mapping and Ablation Catheter (Mesh‐Bard) (2008) (7)
- Abciximab: a reappraisal of its use in coronary care (2008) (7)
- Reproducibility of metabolical parameters during successive coronary sinus pacing in patients known to have coronary artery disease. (1985) (7)
- Heart rate and use of β-blockers in Mexican stable outpatients with coronary artery disease. (2015) (7)
- Ischaemic heart disease: clinical improvement with metabolic approach. (2000) (7)
- Hibernating myocardium in patients with coronary artery disease: Identification and clinical importance (1992) (7)
- Utilization of propionyl-L-carnitine for the treatment of heart failure (1995) (7)
- Aldosterone blockade in post‐acute myocardial infarction heart failure (2006) (6)
- Myocardial ischaemia: new evidence for angiotensin-converting enzyme inhibition (2003) (6)
- Beyond cardiomyocyte loss: Role of Notch in cardiac aging (2018) (6)
- It Is Time to Stop Comparing Blood Pressure–Lowering Drugs With Placebo—Reply (2006) (6)
- Safety and efficacy of coronary sinus narrowing in chronic refractory angina: Insights from the RESOURCE study. (2021) (6)
- Atrial natriuretic peptide: its mechanism of release from the atrium. (1989) (6)
- The effects of L-arginine mono(2-mercaptoethanesulfonate) on the ischemic and reperfused heart. (1992) (6)
- Diabetes, Pre-diabetes and Cardiovascular Diseases (2010) (6)
- Design of the Empagliflozin Cardiovascular (CV) Outcome Event Trial in Type 2 Diabetes (T2D) (2013) (6)
- Highlights of the 2009 scientific sessions of the European Society of Cardiology. (2009) (6)
- Role of timing of administration in the cardioprotective effect of fructose-1,6-bisphosphate (1992) (6)
- Endothelial Dysfunction in Congestive Heart Failure: Effects of Carvedilol (1999) (6)
- Dynamic ventriculography with K-strophantin. (1978) (6)
- Effects of Lercanidipine on Fe2+‐Induced Mitochondrial Lipid Peroxidation (1997) (6)
- OXYGEN· FREE RADICALS AT MYOCARDIAL LEVEL: EFFECTS OF (1994) (6)
- Is stunning an important component of preconditioning? (1996) (6)
- Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study (2018) (6)
- Role of timing of administration in the cardioprotective effect of iloprost, a stable prostacyclin mimetic. (1991) (6)
- Factors influencing cardiac mitochondrial calcium transport and oxidative phosphorylation (1982) (6)
- Profile and treatment of chronic coronary syndromes in European Society of Cardiology member countries: The ESC EORP CICD-LT registry. (2020) (6)
- Efficacy and safety of catheter ablation of atrioventricular nodal re-entrant tachycardia by means of flexible-tip irrigated catheters (2019) (6)
- Effect of Prenalterol on Contractility, Relaxation, and Filling Phase in Coronary Artery Disease Patients with Previous Myocardial Infarction (1984) (5)
- Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (2010) (5)
- Understanding patient needs Myocardial metabolism: the diabetic heart (2003) (5)
- Pathophysiological vs biochemical ischaemia: a key to transition from reversible to irreversible damage (2001) (5)
- Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities. (2021) (5)
- Concerns and hopes for stem cell therapy in cardiology: focus on endothelial progenitor cells. (2010) (5)
- Ferrara I: Introduction: Why and how do cardiologists need to take an interest and lead prevention programmes? (2017) (5)
- Estrogen derivative relaxes rabbit aorta via the endothelial receptor system. (2001) (5)
- Bradykinin and coronary artery disease (2000) (5)
- [Perivalvular leak assessment and closure: role of real-time three-dimensional transesophageal echocardiography]. (2012) (5)
- Abstract 16065: Sex-Specific Benefits of Sirolimus Eluting Stent on Long Term Outcomes in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Insights From the MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abcixim (2011) (5)
- Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease. (2021) (5)
- Mechanism of myocardial protective action of dilazep during ischaemia and reperfusion. (1987) (5)
- D,L-Carnitine and D,L-acetylcarnitine actions on myocardial contractility and coronary resistance in isolated perfused rabbit hearts. (1980) (5)
- Quality of life with ivabradine in patients with angina pectoris: The SIGNIFY Quality of Life substudy (2015) (5)
- Intracardiac flow analysis in cardiac resynchronization therapy: A new challenge? (2019) (5)
- b -blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study (2018) (5)
- Anti-cytokine therapy in chronic heart failure: new approaches and unmet promises (2004) (5)
- [Beyond dyssynchrony: what are the factors determining the response to cardiac resynchronization therapy?]. (2008) (5)
- Ivabradine in stable coronary artery disease. (2014) (5)
- New and old strategies to afford the liberal use of drug-eluting stents in real-life scenarios (2005) (5)
- Carnitine and lactate metabolism (1995) (5)
- The “in vivo” and “in vitro” effects of nicardipine on coronary resistances and myocardial performance (1983) (5)
- Combining New Classes of Drugs for HFrEF: from Trials to Clinical Practice. (2021) (5)
- Myocardial lactic acid balance after left ventriculography. (1980) (5)
- Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure (1993) (4)
- Simple risk models to predict cardiovascular death in patients with stable coronary artery disease (2020) (4)
- Heart Rate Management in Stable Angina (2005) (4)
- Prognosis after pacemaker implantation in extreme elderly. (2019) (4)
- The ‘Black Death’ and the physician at the time of COVID-19 (2020) (4)
- Cardioprotection with ACE inhibitors : non-angiotensin II-related mechanisms (2000) (4)
- The Cardiologist at the time of Coronavirus: a perfect storm (2020) (4)
- The Combination of Chest Computed Tomography and Standard Electrocardiogram Provides Prognostic Information and Pathophysiological Insights in COVID-19 Pneumonia (2021) (4)
- The influence of right heart catheterisation on pulmonary arterial pressure in chronic heart failure: relationship to neuroendocrinal changes. (1991) (4)
- Time Dependence of the Cardioprotective Effects of Lercanidipine (1997) (4)
- ACE-Inhibition for Secondary Prevention of Cardiovascular Events—Should We Change Our Recommendation After PEACE? (2006) (4)
- Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting (2010) (4)
- One heart, two lungs together forever. (2006) (4)
- [Magnetic resonance imaging for the evaluation of patients undergoing cardiac resynchronization therapy. Advantages, limitations and perspectives]. (2010) (4)
- Diastolic dysfunction, frailty and prognosis in elderly patients with acute coronary syndromes. (2020) (4)
- Particular outcomes of myocardial ischaemia: stunning and hibernation. (1995) (4)
- Oxidative Stress and Ventricular Dysfunction in Ischemic Heart Disease (1999) (4)
- Temporal and Genotype-Driven Variation of Factor VII Levels in Patients With Acute Myocardial Infarction (2009) (4)
- [Activation and role of the tumor necrosis factor-alpha in congestive heart failure]. (1996) (4)
- Different outcomes of the reperfused myocardium: insights into the comments of stunning and hibernation. (1998) (4)
- Effect of lacidipine on ischaemic and reperfused isolated rabbit hearts (1993) (4)
- Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease (2019) (4)
- Importance of oxygen free radicals during ischaemia and reperfusion in the experimental and clinical setting (1991) (4)
- Recognized molecular mechanisms of heart failure: approaches to treatment. (1998) (4)
- Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: protocol for a systematic review and meta-regression analysis (2018) (4)
- Glucose and FFA as myocardial substrate during ischaemia: Effects on glutathione status (1986) (4)
- Combined evaluation of perfusion and function for the identification of viable myocardium. (1992) (4)
- The control of heart rate: the physiology of the sinoatrial node and the role of the I f current (2006) (4)
- Living with stable angina: patients' pathway and needs in angina. (2020) (4)
- Origin of heart failure: cardiac or generalized myopathy? (1999) (4)
- Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. Data from the international CLARIFY registry (2013) (4)
- Coronary sinus lactate release as an index of myocardial anaerobiosis: effects of interventions. (1986) (4)
- Commentary on myocardial stunning and its clinical relevance (1995) (4)
- Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. (2014) (4)
- Key words to be adopted for COVID-19 research (2020) (4)
- Coronary artery disease: Use of ACE inhibitors in stable CAD—what is the truth? (2014) (3)
- Treatment with angiotensin-converting enzyme inhibitors: insight into perindopril cardiovascular protection (2008) (3)
- The effects of intravenous nifedipine on cardiac hemodynamics and contractility in patients with coronary artery disease in the presence or absence of beta adrenergic blockade (1987) (3)
- Lipid Peroxidation-Induced Mitochondrial Damage : Analogies with Ischaemic and Reperfusion Injury (1986) (3)
- Insufficient control of heart rate in stable coronary artery disease patients in Latvia. (2014) (3)
- A symposium : metabolic management of ischemic heart disease (1998) (3)
- Protective effects of delapril, indapamide and their combination on stroke occurrence and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats. (1998) (3)
- A modern fairy tale (2009) (3)
- Metabolic management of ischemic heart disease: introduction (1998) (3)
- Protective Effects of Calcium Antagonists Against Ischaemia and Reperfusion Damage (2012) (3)
- Grown Up Congenital Heart Disease (2010) (3)
- Ischemic preconditioning of the myocardium as a result of adaptation of enzymes catalyzing energy consuming processes to decreased accessibility of metabolic energy. A theoretical study based upon real measurements. I (1992) (3)
- Favouring myocardial viability to necrosis: a challenge in ischaemic heart disease with prognostic complications. (2001) (3)
- [Acute myocardial infarction with persistent ST segment elevation: towards an appropriate diagnostic and therapeutic approach in the health care community]. (2002) (3)
- Effects of anipamil on myocardial sarcolemmal and mitochondrial calcium transport, comparison with verapamil and nifedipine. (1992) (3)
- Metabolic disarrangement in ischemic heart disease and its therapeutic control. (1998) (3)
- Protection of the ischaemic heart (1983) (3)
- Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock. (2013) (3)
- Insight into cytoprotection with metabolic agents (1999) (3)
- Profile and treatment of chronic coronary syndromes in European Society of Cardiology member countries: The ESC EORP CICD-LT registry. (2021) (3)
- The LMNA/C Missense Mutation R216C Pinpoints Overlapping Features Between Brugada Syndrome and Laminopathies. (2020) (3)
- Left ventricular output indices in hospitalized heart failure: when “simpler” may not mean “better” (2020) (3)
- Effects of isoproterenol (I) on the release of atrial natriuretic peptide (ANP) from isolated atria. (1992) (3)
- Evaluation of left ventricular systolic function during atrial fibrillation: Is it reliable? (2018) (3)
- Current Role of Echocardiography in Cardiac Resynchronization Therapy: from Cardiac Mechanics to Flow Dynamics Analysis (2020) (3)
- Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs? (1999) (3)
- Atlas of the Myocardium (1992) (3)
- The multifaceted angina (2019) (3)
- Cardiovascular protection by angiotensin-converting enzyme inhibition (2009) (3)
- Effects of atrial rate on the release of atrial natriuretic peptide-like immunoreactive material from rat atrium in vitro (1987) (3)
- The story of the heartbeat, I: part I—heart rate: the rhythm of life. (2012) (3)
- [Effect and action mechanism of hypothermia to preserve the ischaemic myocardium (author's transl)]. (1980) (3)
- Cardiac Calcifications: Phenotypes, Mechanisms, Clinical and Prognostic Implications (2022) (3)
- Effects of felodipine on the ischemic heart: Insight into the mechanism of cytoprotection (1996) (3)
- Differences in outcomes in patients with stable coronary artery disease managed by cardiologists versus noncardiologists. Results from the international prospective CLARIFY registry. (2017) (3)
- Long‐Lasting Protective Effect of Anipamil, a New Calcium Entry Blocker, against Myocardial Ischemia and Reperfusion Damage (1988) (3)
- How European cardiologists perceive the role of calcium antagonists in follow-up after myocardial infarction. (1997) (3)
- Effect of acute and chronic treatment with propionil-l-carnitine on mechanical performance of isolated heart (1989) (3)
- Ivabradine in the management of coronary artery disease with or without left ventricular dysfunction or heart failure (2015) (3)
- Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban (2010) (3)
- Possible mechanisms of the protective effect of pretreatment with anipamil in ischemic-reperfused isolated rat hearts. (1992) (3)
- Beta-blockers and COPD: how can harmony be restored in a marriage in crisis? (2020) (3)
- Effects of anipamil on myocardial sarcolemmal and mitochondrial calcium transport, comparison with verapamil and nifedipine (1990) (3)
- Circulating Biomarkers of Endothelial Dysfunction and Inflammation in Predicting Clinical Outcomes in Diabetic Patients with Critical Limb Ischemia (2022) (2)
- Factor XIIIA-V 34 L and Factor XIIIB-H 95 R Gene Variants : Effects on Survival in Myocardial Infarction Patients (2007) (2)
- Myocardial Response to Reperfusion after a Prolonged Period of Ischaemia (1992) (2)
- β-blockers across the cardiovascular continuum: cardioprotection and cardioselectivity (2014) (2)
- Tirofiban: a critical reappraisal of the clinical use, recent developments and future perspectives. (2006) (2)
- Relation between energy metabolism, glycolysis, noradrenaline and duration of ischaemia (1992) (2)
- [Right ventricular heart failure in hyperthyroidism]. (2001) (2)
- Carnitine and Cardiac Energy Supply (1988) (2)
- TNFalpha in patients with congestive heart failure. (2004) (2)
- High-Sensitivity Cardiac Troponin Predicts Major Cardiovascular Events in Diabetic Patients With Critical Limb Ischemia and Foot Lesions (2021) (2)
- A New Risk Chart for Acute Myocardial Infarction by a Innovative Algoritm (2015) (2)
- [Comparative protective effect of gallopamil in myocardial ischemia and reperfusion]. (1987) (2)
- Cardiovascular Disease during Pregnancy (2010) (2)
- Baseline characteristics of participants enrolled in the empagliflozin cardiovascular outcome trial (EMPA-REG OUTCOME™) in patients with type 2 diabetes (2014) (2)
- Understanding ARNIs. (2019) (2)
- REVERSIBLE LEFT VENTRICULAR DYSFUNCTION: DOES IT AFFECT CLINICAL PRACTICE AND DOES IT MATTER? (1998) (2)
- Reversible and irreversible ischaemic damage: importance of energy metabolism. (1984) (2)
- Angina and chronic obstructive pulmonary disease: facing the perfect storm (2019) (2)
- A Clinical Case of Catecholaminergic Polymorphic Ventricular Tachycardia: The Clinical Suspicious and the Need of Genetics (2017) (2)
- Prevalence, Incidence and Prognostic Implications of Left Bundle Branch Block in Patients with Chronic Coronary Syndromes (From the CLARIFY Registry). (2021) (2)
- Effect of cardiac failure in rats on myocardial concentrations of noradrenaline and on atrial ANP-bombesin-and neurotensin-like imunoreactivity (1987) (2)
- Coronary artery disease imaging : what is the role of magnetic resonance imaging ? (2018) (2)
- Abstract 316: Heart Rate Reduction Prevents The Global Phenotype Of Post-myocardial LV Infarction Remodeling (2007) (2)
- Rosuvastatin stimulates eNOS and inhibits apoptosis in HUVECs exposed to sera from cardiovascular diseases patients (2007) (2)
- Compendium of Abridged ESC Guidelines 2010 (2010) (2)
- Tumor Necrosis Factor-Alpha in Chronic Heart Failure (1995) (2)
- The impossible interviews—Sherlock Holmes interviews David Sackett: ‘how much can we trust the guidelines?’ (2021) (2)
- Tissue Doppler deformation imaging identifies myocardial stunning occurring during the Tako-Tsubo syndrome. Case report in a Caucasian patient. (2007) (2)
- The story of the heartbeat, II. (2012) (2)
- How can the European Society of Cardiology ensure compliance with ethical standards? (2016) (2)
- β-Adrenergic receptors and intracellular signalling pathway in stunned and non-ischemic regions of pig myocardium (2001) (2)
- [Current options to manage clopidogrel poor responsiveness]. (2010) (2)
- The Search for the Hibernating Myocardium — Have We Reached the Limit? (1999) (2)
- [Evaluation of QRS voltage in 12 derivations and Cornell criteria in the diagnosis of left ventricular hypertrophy]. (1994) (2)
- Lactate production after left ventricular angiography in coronary artery disease. (1978) (2)
- Acute vs. chronic treatment with propionyl-L-carnitine: biochemical, hemodynamic and electrophysiological effects on rabbit heart (1995) (2)
- Study of Notch signaling modulation by shear stress by using an ex vivo cone-and-plate system (2015) (2)
- The journey of omega-3 fatty acids in cardiovascular medicine (2020) (2)
- Cardiomyology: an attempt to link structural cardiac and skeletal muscle damage in patients with dilated cardiomyopathy (2004) (2)
- Treating angina (2019) (2)
- ‘Corona’ versus ‘coronary’ (2020) (2)
- gINTELLIGENCE WHF/AHA/ACCF/EHN/ESC PRESIDENTIAL ADVISORY Our Time: A Call to Save Preventable Death From Cardiovascular Disease (Heart Disease and Stroke) (2012) (2)
- Effects of the novel calcium channel blocker, anipamil, on the isolated rabbit heart (1992) (2)
- Heart failure in the community and in hospitals : selection and survival of patients in different settings (2003) (2)
- PERTINENT: AUTHORS' RETROSPECTIVE (2012) (2)
- [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)]. (2005) (2)
- The European Society of Cardiology ACCA-EAPCI Registry on ST elevation myocardial infarction. (2017) (2)
- [Hemodynamic and neuroendocrine profile of 2 different cardiovascular responses in vasodepressor syncope induced by the head-up tilt test]. (1992) (2)
- Protective effect of anipamil preteatment during myocardial ischaemia andreperfusion (1984) (2)
- Abstract 5066: The Treatment Effect of Perindopril is Consistent in All Patients with Vascular Disease or High Risk of Vascular Disease: A Combined Analysis of Three Perindopril Trials (2008) (2)
- Effect of ivabradine on structural and electrophysiological remodelling in a rat model of heart failure (2007) (1)
- The Aswan Heart Centre project. (2013) (1)
- Paradoxical low-flow phenotype in hospitalized heart failure with preserved ejection fraction (2020) (1)
- Cardiovascular disease. Preface. (2009) (1)
- The role of carbocromene in substrate utilization during ischaemia and reperfusion (1983) (1)
- Effect of calcium antagonists and nitroglycerine on rabbit aortic and coronary smooth muscle (1985) (1)
- The impact of periprocedural myocardial infarction on mortality in older adults with non-ST-segment elevation acute coronary syndrome: a pooled analysis of the FRASER and HULK studies (2021) (1)
- [Is lipid peroxidation responsible for the damage caused by postischemic reperfusion?]. (1991) (1)
- The harmful effects of aldosterone in heart failure (2000) (1)
- Do the stress proteins influence the mitochondrial functions (1992) (1)
- Use of risk score to identify lower and higher risk subsets among COMPASS-Eligible patients with stable CAD. Insights from the CLARIFY Registry (2020) (1)
- Serum from heart failure patients modulates Notch signalling in human umbelical vein endothelial cells. (2013) (1)
- Percutaneous coronary injection of bone marrow cells in small experimental animals: small is not too small. (2007) (1)
- The effects of a new calcium entry blocker “Anipamil” on rabbit myocardium and aortic smooth muscle (1984) (1)
- European Heart for Children: a story of humanity and success. (2015) (1)
- Heart failure and catheter ablation of atrial fibrillation: Navigating the difficult waters of heart failure phenotypes. (2022) (1)
- Cardiac Phosphatidylethanolamine N-Methylation in Normal and Diabetic Rats Treated with L-Propionylcarnitine (1990) (1)
- Myocardial metabolism: the diabetic heart (2003) (1)
- How should we measure cytokines in heart failure? [8] (1996) (1)
- [Role of cardiac imaging in the diagnosis of infective endocarditis]. (2020) (1)
- Pulmonary hypertension at high altitudes (1986) (1)
- Protective effects of gallopamil against ischemia and reperfusion damage. (1989) (1)
- Role of Oxygen in Myocardial Ischaemia and Reperfusion Damage (1989) (1)
- How European cardiologists perceive the role of calcium antagonists in the treatment of stable angina. (1997) (1)
- Oxidative stress during ischaemia and reperfusion in human (1987) (1)
- A strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction. (2008) (1)
- 2019 guidelines for the diagnosis and management of chronic coronary syndromes: congratulations and criticism (2020) (1)
- Cardiologists and their war on platelets. (1999) (1)
- PP.07.30: PERINDOPRIL AND BETA-BLOCKER FOR THE PREVENTION OF CARDIAC EVENTS AND MORTALITY IN STABLE CAD PATIENTS A EUROPA SUBANALYSIS (2015) (1)
- Healthy versus sick myocyte: metabolism, structure, and function Defining the friends and foes (2009) (1)
- Reproducibility of metabolic parameters during atrial pacing stress in cad patients (1981) (1)
- [Myocardial cellular mechanism of action of calcium antagonists]. (1985) (1)
- [Latest news and perspectives in cardiogenetics]. (2018) (1)
- Relationship between PCSK9 and endothelial function in patients with acute myocardial infarction. (2022) (1)
- Physical training in chronic heart failure: much more than training. (2002) (1)
- Protective effect of α-tocopherol on cardiac muscle function during hypoxia and after reoxygenation (1977) (1)
- The Impact of Surgical and Trans-Catheter Aortic Valve Replacement on Endothelial Function: New Markers Ahead (2018) (1)
- Similarities between fibroblasts and cardiomyocytes in the study of the permeability transition pore (2022) (1)
- Endothelial dysfunction and heart failure. (2001) (1)
- [Calcium channels: multiplicity, function and origin]. (1997) (1)
- Looking for a Tailored Therapy for Heart Failure: Are We Capable of Treating the Patient Instead of the Disease? (2021) (1)
- Pro-inflammatory genetic profile and familiarity of acute myocardial infarction (2012) (1)
- European Heart for Children (2010) (1)
- Circulation CLINICALINVESTIGATION Regular Physical Exercise andLow-Fat Diet: Effects onProgression ofCoronary Artery Disease (1992) (1)
- Neuroendocrine Response to Heart Failure (1993) (1)
- Alterations of glutathione metabolism and of GPD activity during myocardialischaemia and reperfusion (1984) (1)
- Frequency, management and outcomes of patients with stable coronary artery disease eligible for COMPASS. An analysis of the CLARIFY Registry (2020) (1)
- The Pharmacological Protection of the Ischaemic Heart (1979) (1)
- Effects of prolonged infusion of calcitonin gene-related peptide on the hemodynamics, hormones and renal blood flow in congestive heart failure (1991) (1)
- Changes in atrial specific granules and atrial natriuretic factor release in experimental congestive cardiac failure (1989) (1)
- 2013 ESH/ESC Guidelines for the management ofarterial hypertension (2013) (1)
- Colesterolo e rischio cardiovascolare : percorso diagnostico-terapeutico in Italia = Hypercholesterolemia and cardiovascular risk: diagnostic and therapeutic pathways in Italy (2016) (1)
- Effect of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a summary (1995) (1)
- Differences in outcomes in patients with stable coronary artery disease managed by cardiologists versus non-cardiologists : the international prospective CLARIFY registry (2017) (1)
- Commentary on hibernating myocardium and its clinical relevance (2004) (1)
- [Echocardiography in ST-elevation myocardial infarction]. (2018) (1)
- Ergometrine action on rabbit coronary vessels. (1980) (1)
- [Effect of nicardipine on myocardial contractility and coronary tone in vitro]. (1987) (1)
- Release of factor neurotensin and bombesine from stretched rat atrium (1986) (1)
- Ferrara V. (2018) (1)
- DETERMINATION OF THE URINARY NEUTROPHIL GELATINASE–ASSOCIATED LIPOCALIN AS AN EARLY MARKER OF CONTRAST INDUCED ACUTE KIDNEY INJURY AFTER CORONARY CATHETERIZATION (2013) (1)
- Glucose and FFA as myocardial substrate during ischemia (1981) (1)
- Effects of temperature and osmolality on the release of atrial natriuretic peptide. (1990) (1)
- Glycolysis, catecholamine release and energy metabolism during recurrent cardiac ischemia (1992) (0)
- WITHDRAWN: Prognostic value of predischarge echo-doppler in elderly after acute myocardial infarction: The preami echo study (2007) (0)
- [New findings on cardiac metabolism in ischemic cardiopathy]. (1991) (0)
- From optimization of mitochondrial metabolism to myocardial viability : how to assess myocardial cytoprotection in coronary patients : satellite symposium held during the XVII Congress of the European Society of Cardiology, Amsterdam, The Netherlands, August 22, 1995 (1996) (0)
- Pathogenesis ofEdema inConstrictive Pericarditis Studies ofBodyWaterandSodium, RenalFunction, Hemodynamics, andPlasmaHormones Before andAfter Pericardiectomy (1991) (0)
- Down-regulation of receptors for atrial natriuretic factor release during congestive cardiac failure (1989) (0)
- [Echocardiographic assessment of mitral regurgitation in the perspective of valve repair]. (2017) (0)
- Clinical applications of trimetazidine in ischaemic heart disease (2001) (0)
- Effects of nitric oxide on energy metabolism in peripheral muscle (2000) (0)
- The Role of Free Radical Scavengers in Reperfusion (1988) (0)
- [Refractory heart failure. Antagonism of tumor necrosis factor alpha and endothelin in humans: 2 promises still to be honored]. (2002) (0)
- [Endothelium in the control of vascular tone: the physiological role]. (1998) (0)
- [Cardiac adaptation and maladaptation]. (1996) (0)
- [Release of atrial natriuretic factor following the stretching of the atrium of rats in vitro]. (1987) (0)
- Aldosterone in syndromes of untreated congestive heart failure (1996) (0)
- Abnormal Mitochondrial Oxidative Phosphorylation of Ischaemic and Reperfused Myocardium Reversed by L-Propionyl-Carnitine (1992) (0)
- [PP.13.01] THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER THERAPY IN PATIENTS WITH VASCULAR DISEASE (2016) (0)
- The Mediterranean diet: a cultural journey – Authors' reply (2011) (0)
- The heart rate : a simple concept with unrevealed clinical implications (1999) (0)
- Auto-immune activation in severe heart failure patients (2000) (0)
- Atrial Fibrillaton (AF) (2010) (0)
- Effect of D-600 on ischaemic and reperfused myocardium: Relation with timing and modality of administration (1989) (0)
- 151 Predischarge echo-Doppler predictors of late cardiac remodeling in the placebo arm of the PREAMI Echo Study (2006) (0)
- A.104 Role of pulmonary and bronchial circulation in neutrophil-mediated lung damage induced by cardiopulmonary bypass (1996) (0)
- [Neuroendocrine and metabolic aspects of heart failure]. (1987) (0)
- Incidence of diagnosis of heart failure made by general practitioners and survival rate of the patients: Data from 696884 persons in the UK (2000) (0)
- Neuroendocrine responsetostanding andmild exercise inpatients withuntreated severe congestive heart failure andchronic constrictive pericardit'is (1996) (0)
- Acute hemodynamic and neurohumoral effects of the oral dopamine derivative ibopamine in patients with heart failure. (1989) (0)
- [How severe is mitral regurgitation? Possibilities and problems of echocardiographic evaluation in clinical practice]. (2018) (0)
- [Hemodynamic effects induced by the combined administration of sodium nitroprusside and ibopamine in patients with congestive heart decompensation]. (1985) (0)
- Anti-ischemic effect of IVA in isolated rabbit hearts: Modulation of cardiac metabolism (2007) (0)
- Rosuvastatin stimulates endothelial nitric oxide synthase and inhibits apoptosis in human endothelial cells (2007) (0)
- Right and left auricular concentration of atrial natriuretic peptide in normal and failing human heart (1990) (0)
- Inhibition of rat heart hypertrophy by 1-3 diaminopropane (DAP) (1981) (0)
- Assessment of acute myocardial infarction evolution in patients undergoing primary angioplasty or thrombolytic therapy: A gated-SPECT longitudinal evaluation study (2005) (0)
- EUROPEAN HEART JOURNAL SUPPLEMENTSKey lessons from morbidity/mortality trials: evidence for benefits of the perindopril/amlodipine combination ESC MUNICH 2008 (2008) (0)
- Sunday, 18 July 2010 (2010) (0)
- Metabolism of ischemic and reperfused myocardium (1981) (0)
- Comparative study of the antioxidant and immunomodulant activities between yeast and lab fermented papaya (2018) (0)
- Prevention of Stroke and major cardiovascular events with perindopril-based treatment: The PROGRESS trial (2008) (0)
- Pulmonary haemodynamics oftheyak,cattle, and crossbreeds athighaltitude (1986) (0)
- Pathogenesis ofoedemainchronic severe anaemia: studies ofbodywater andsodium, renal function, haemodynamic variables, andplasma hormones (1993) (0)
- Geographic variations in prevalence and management of cardiovascular risk factors in 33 283 outpatients with CAD: data from the contemporary CLARIFY registry from 45 countries (2013) (0)
- Pathogenesis ofCongestive State inChronic Obstructive Pulmonary Disease Studies ofBodyWaterandSodium, RenalFunction, Hemodynamics, andPlasmaHormones During EdemaandAfter Recovery (1992) (0)
- Effects of l-propionil-carnitine on myocardial damage induced by erucic acid (1988) (0)
- Angina and left ventricular dysfunction: can we ‘reduce’ it? (2019) (0)
- [New findings on calcium antagonism]. (1992) (0)
- [The importance of demonstration of aortic insufficiency in the angiographic diagnosis of Valsalva's sinus aneurysm]. (1976) (0)
- ‘ ‘ Myocardial stunning ’ ’ remaining questions 1 (1998) (0)
- 7.3 Prevention of paroxysmal atrial tachyarrhythmias through pacing. evaluation of different atrial pacing modalities (2003) (0)
- What is the role of increased heart rate in acute coronary syndromes (2010) (0)
- Bio-energetics, Metabolism and Nutrition: from molecules to systems (2018) (0)
- WITHDRAWN: Effects of perindopril on late cardiac remodeling in elderly patients after acute myocardial infarction: The preami echo study (2007) (0)
- A.173 Noradrenaline reduces nitric oxide production in human endothelial cells (1996) (0)
- Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes. (2023) (0)
- Effect of heart rate reduction in coronary artery disease and heart failure (2016) (0)
- The need to improve acute heart failure treatment (2016) (0)
- Mechanism of action of ergonovine in rabbit aortic smooth muscle (1985) (0)
- Response by Mele et al to Letter Regarding Article, "Novel Echocardiographic Approach to Hemodynamic Phenotypes Predicts Outcome of Patients Hospitalized With Heart Failure". (2020) (0)
- [Markers of coronary damage. From diagnosis to prognosis]. (2005) (0)
- Measurement of free malondialdehyde during myocardial ischaemia and reperfusion injury (1990) (0)
- [Effects of dilazep on the myocardium and smooth vascular muscle]. (1987) (0)
- AMI in Patients Presenting with Persistent ST-Segment Elevation (2010) (0)
- In vitro ergothioneine administration failed to protect isolated ischaemic and reperfused rabbit heart. (1994) (0)
- [Preferential therapeutic indications for calcium antagonists]. (1985) (0)
- Acute Pulmonary Embolism (2010) (0)
- Acute and Chronic Effects of Nisoldipine in Patients with Chronic Heart Failure (1991) (0)
- [Heart failure in the elderly: differences, problems, and uncertainty]. (1999) (0)
- Acute and Chronic Heart Failure (2010) (0)
- [Metabolic and functional correlations during post-ischemic reperfusion]. (1982) (0)
- Beneficial effects of propionyl L-carnitine in congestive heart failure ☆ (1992) (0)
- A quantitative assay for atrial natriuretic factor (ANF)-mRNA (1992) (0)
- EHJ Supplement—the Heart of the Matter, UPDATE. (2016) (0)
- A New Risk Chart of Acute Myocardial Infarction in Men by an Innovative Algorithm: A Pilot Study (2015) (0)
- [Neurohormonal changes which occur in heart failure and their clinical significance]. (1988) (0)
- Effects of ischaemia and reperfusion on glutathione metabolism (1983) (0)
- A Sample-Saving Preparation to Extract DNA-Binding Proteins from Cardiac and Vascular Tissues (2002) (0)
- Cardiac hypertrophy induced by pressure overload is mediated by LIF/STAT3 activation (2007) (0)
- Effects of aging and hypercolesteremia on ischaemic reperfusion damage (1992) (0)
- [Echocardiography with reconstructed M-mode: technical aspects and clinical applications]. (2002) (0)
- Tu-P7: 148 Rosuvastatin stimulates endothelial nitric oxide synthase and inhibits apoptosis in human endothelial cells (2006) (0)
- New Evidence on the Pathological Role of Permeability Transition Pore in Patients with STEMI (2020) (0)
- [Heart muscle mitochondria function in alpha-tocopherol deficient rabbits. (author's transl)]. (1981) (0)
- Role of neutrophil activation in the occurrence of oxidative stress during myocardial ischaemia and reperfusion in humans (1990) (0)
- The pharmacological control of calcium (1988) (0)
- [Different action of strophanthin on asynergic and normokinetic areas of the left ventricle in coronary insufficiency]. (1977) (0)
- The effect of hypothermia on mitochondrial function on ischaemic and reperfused myocardium (1981) (0)
- Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes, and smoking. (2020) (0)
- Clinical practice guidelines of the ESC on myocardial revascularization, 2014 (2015) (0)
- [The efficacy of the angiographical method in the evaluation of left ventricular muscle mass in the dog (author's transl)]. (1977) (0)
- Ischaemia, hibernation, and viability (2021) (0)
- plasma hormones . renal function , haemodynamic variables , and anaemia : studies of body water and sodium , Pathogenesis of oedema in chronic severe (0)
- Major unmet needs in the cardiovascular area (2018) (0)
- Skeletal muscle alterations in rats with experimentally‐induced myocardial hypertrophy and failure (2000) (0)
- Operator, Drug or Device: Who Will Break Down Acute Stent Thrombosis? (2017) (0)
- Prevention of myocardial infarction with ACE inhibitors : a global need - (2015) (0)
- P3986Circulating microRNAs correlate with heart failure presence and progression (2017) (0)
- [Changes in left ventricular volume during angiocardiography. Experimental study]. (1977) (0)
- Rapid centrifugal movement of atrial specific granules induced by stretch (1988) (0)
- Protective effect of propionil-carnitine against mitochondrial membrane lipid peroxidation (1985) (0)
- Clinical predictors of ACE-inhibitor induced dry cough in 27492 patients with cardiovascular disease using individual data of randomized clinical trials (2013) (0)
- New onset of chest pain: the importance of remote monitoring (2019) (0)
- Erratum to: ACE Inhibition Modulates Endothelial Apoptosis and Renewal via Endothelial Progenitor Cells in Patients with Acute Coronary Syndromes (2012) (0)
- The role of free radicals in the ischemic myocardium. (1991) (0)
- Effects of Lacidipine on Ischemic and Reperfused Myocardium (1993) (0)
- ImprovedProcedurefor DeterminingGlutathionein Plasmaas an Indexof MyocardialOxidative Stress (1987) (0)
- Combined clinical and pharmacogenetic risk scoring model determines ACE-inhibitor treatment benefit in patients with stable coronary artery disease (2013) (0)
- Cardiac Pacing and Cardiac Resynchronization Therapy (2010) (0)
- Single-pill combination in the management of chronic coronary syndromes: A strategy to improve treatment adherence and patient outcomes? (2023) (0)
- [OP.4A.11] THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER THERAPY IN PATIENTS WITH VASCULAR DISEASE AND HYPERTENSION (2017) (0)
- [Myocardial damage caused by ischemia and reperfusion: role of oxygen toxicity]. (1988) (0)
- Hormonal changes after combined percutaneous mitral and tricuspid balloon valvuloplasty. (1994) (0)
- Estrogen receptor β is involved in 17β-estradiol-mediated Notch1 activation and angiogenesis enhancement in human endothelial cells (2015) (0)
- [Effect of vitamin E on cardiac muscle function and metabolism during anoxia and after reoxygenation (author's transl)]. (1979) (0)
- Prevention and Control of Cardiovascular Diseases: Integrated and Complimentary Strategies (2015) (0)
- How to overcome aspirin and P 2 Y 12 blocker resistance in secondary prevention in high-risk patients ? - (2011) (0)
- WITHDRAWN: Predischarge echo-doppler predictors of late cardiac remodeling in the placebo arm of the preami echo study (2007) (0)
- [Prevention of myocardial damage by oxygen free radicals. Theoretical premises and experimental data]. (1985) (0)
- [Effect of re-oxygenation on the metabolism of free nucleotides and nucleic acids in the anoxic heart]. (1975) (0)
- Cardiovascular protection: a breakthrough for high-risk patients? (2009) (0)
- 139 Secondary cardiomyopathy in patients with Beta‐thalassemia major: a model of reverse cardiomyopathy (2008) (0)
- 4054Betablockers and outcomes in stable coronary artery disease. Insights from the CLARIFY registry (2018) (0)
- Role of bradykinin and cNOS pathway in the cardioprotective effect of trandolapril (2000) (0)
- NORMOTENSIVE RATS ( WKY ) 2 MONTHS 6 MONTHS 18 MONTHS HSP 72 • HYPERTENSIVE RATS (2005) (0)
- Effect of calcium entry-blockers and nitroglycerine on rabbit aortic strips in normal and in calcium free conditions (1984) (0)
- Modulación metabólica y optimación del consumo de energía en la insuficiencia cardíaca (2003) (0)
- A GREAT LEAP FORWARD IN THE MANAGEMENT OF ATRIAL FIBRILLATION (2013) (0)
- [Protective effect of verapamil on the damage caused by coronary insufficiency. Experimental research]. (1978) (0)
- Early predictors of ventricular remodeling after myocardial infarction (2007) (0)
- [Tumor necrosis factor and heart failure]. (1998) (0)
- Alternative mechanisms of nitric oxide mediated vasodilation: Experimental evidence (2000) (0)
- The distribution of neurotensin-, bombesin-, VIP and atrial natriuretic peptide-like immunoreactivity in mouse (1987) (0)
- Evidence against malondialdehyde bound to cellular constituents in phospholipid peroxidation. (1994) (0)
- Posters display III clinical outcome and PET (2005) (0)
- ACE inhibition and myocardial ischemia--new challenge for the third millennium. Proceedings of a satellite symposium of the XXth Congress of the European Society of Cardiology. Vienna, Austria, August 1998. (1998) (0)
- IC4 ECONOMIC ANALYSIS OF THE STRATEGY STUDY: TIROFIBAN AND DRUG ELUTING STENTS VERSUS ABCIXIMAB AND BARE METAL STENTS (2005) (0)
- What Happened to Electrocardiogram as a Screening Test to Recognize Cardiovascular Complications in COVID-19 Patients? (2020) (0)
- [Metabolism and function of peripheral muscles in heart failure: pharmacologic effects]. (1995) (0)
- European Heart Journal Supplement – the Heart of the Matter (2014) (0)
- [Inhibitory activity of D-600 on smooth vascular tissue: comparison with nifedipine, verapamil and diltiazem]. (1987) (0)
- INTERventional treatment for CARDIovaScular life-threatening diseases (Why is the INTERCARDIS an important project for the cardiological community?): strategies for improving patient outcome and hospital costs (2022) (0)
- [Effect of acidosis on the michondrial function of hearts perfused in hypoxia]. (1978) (0)
- FIBRILLATION IN A LARGE COHORT OF PATIENTS (2015) (0)
- Corrigendum to "Anti-anginal drugs: Systematic review and clinical implications" [Int. J. Cardiol. 283 (2019) 55-63]. (2020) (0)
- Differential action of ACE inhibitors on the eNOS pathway (2007) (0)
- Are neutrophilseutrophils involved in the oxidative stress occurring in man during post-ischaemic reperfusion? (1992) (0)
- [Neuropeptides in human carotid gliomas]. (1987) (0)
- ROLE OF FREE RADICAlS IN THE DEVELOPMENT OF ISCHEMIC HEART DISEASE (1990) (0)
- Inflammatory molecules induce arginase activity in human endothelial cells (2000) (0)
- Beta‐adrenergic receptor pathway in ischaemic and non‐ischaemic regions of pig myocardium (2000) (0)
- Antioxidant protection against ischaemia: Effect of 2,3-Dimercapto-1-propanol (1988) (0)
- [OP.5C.09] AGE-RELATED TREATMENT BENEFIT OF AN ACE INHIBITOR ON CARDIOVASCULAR EVENTS: THE EMERGING ROLE OF BRADYKININ (2016) (0)
- [ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Consensus document. Hypercholesterolemia and cardiovascular risk: diagnostic and therapeutic pathways in Italy]. (2016) (0)
- Effects of glucose and FFA as ischaemic substrate on glutathione status (1986) (0)
- Life and Death of the Endothelium and Myocyte: Cause of Atherosclerosis and Remodeling (2011) (0)
- Metabolic treatment of myocardial ischaemia. (1999) (0)
- Use of Very Small Embryonic-like (VSEL) Stem Cells and Cardiac Stem Cells for Repair of Myocardial Infarction(Special Lecture 3,The 73rd Annual Scientific Meeting of The Japanese Circulation Society) (2009) (0)
- Renin-Angiotensin-Aldosterone System Inhibitors, Statins, and Beta-Blockers in Diabetic Patients With Critical Limb Ischemia and Foot Lesions (2022) (0)
- What is the role of increased heart rate and why is it beneficial to reduce it (2010) (0)
- Tu-P7: 149 Rosuvastatin: Its effects on human endothelial cells exposed to sera from patients with cardiovascular diseases (2006) (0)
- The influence of right heart catheterisation on pulmonary pressure in chronic heart failure: relationship to neuroendocrinal changes arterial (1991) (0)
- Glutathione redox status: A sensor for NFκB activation during post‐ischaemic reperfusion (2000) (0)
- [Intracavitary electrophysiological study of sinus node function in humans after potassium overloading]. (1980) (0)
- Studies on the cardiovascular activities of growth hormone (2002) (0)
- [Protective effect of nicardipine in an experimental model of transient myocardial ischemia in anesthetized dogs]. (1986) (0)
- Reducing cardiovascular risk: evidence from the ONTARGET programme (2009) (0)
- THE IMPACT OF CHRONIC KIDNEY DISEASE ON USE OF EVIDENCE BASED THERAPY IN STABLE CORONARY ARTERY DISEASE: A PROSPECTIVE ANALYSIS OF 22,560 PATIENTS (2013) (0)
- Ivabradine in heart failure: what about digoxin? – Authors' reply (2008) (0)
- [Heart failure: an endothelial disorder?]. (1999) (0)
- TISSUE FACTOR AND COAGULATION FACTOR VII LEVELS DURING ACUTE MYOCARDIAL INFARCTION CONTRIBUTE TO PREDICT MORTALITY AND RE-INFARCTION (2007) (0)
- [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention]. (2005) (0)
- Release of atrial natriuretic factor (ANF) during hearts surgery (1989) (0)
- [Changes in coronary arterial and venous lactate differences after left ventriculography in normal subjects and in patients with coronary disease]. (1977) (0)
- Ace inhibition with perindopril and markers of atherosclerosis and thrombosis: Results of the pertinent study (2007) (0)
- [Toxicity of fatty acids during myocardial reperfusion: a new possible mechanism of action]. (1991) (0)
- [Mitochondrial functionality and homeostasis of CA during experimental ischaemia. Protective action of verapamil (author's transl)]. (1980) (0)
- Effect of chronic infusion of isoproterenol and aitrial natriuretic factor (ANF) on the mechanical and endocrine function of isolated atria (1990) (0)
- [Cardiac resynchronization therapy and reduction of mortality in heart failure: a proven association]. (2007) (0)
- TNFα affects energy metabolism in peripheral muscle via the nitric oxide pathway (2000) (0)
- Reduction of oxidative stress by carvedilol: Role in maintaining myocardial viability in ischaemia (2000) (0)
- L-propionil-carnitine protects against myocardial ischaemic and reperfusion damage (1988) (0)
- [Congestive heart failure. A systemic or a multiregional syndrome?]. (1992) (0)
- [Volumetric study of the diastolic phase in normal subjects and coronary disease patients]. (1980) (0)
- The effects of L-propionyl-carnitine on the ischaemic and reperfused myocardium: A dose-dependence study (1989) (0)
- Metabolic aspects of cardiomyopaties (2006) (0)
- POTENTIAL IMPACT OF THE 2017 ACC/AHA HIGH BLOOD PRESSURE GUIDELINE IN NORMOTENSIVE PATIENTS WITH STABLE CORONARY ARTERY DISEASE: INSIGHTS FROM THE CLARIFY REGISTRY (2018) (0)
- Novel oral anticoagulants in patients with acute coronary syndrome - (2018) (0)
- Contents Vol. 137, 2017 (2017) (0)
- [The double face of oxygen. An introduction to cardiac pathology caused by oxidation injury]. (1986) (0)
- Use of risk scores to identify lower and higher risk subsets among COMPASS‐eligible patients with chronic coronary syndromes. Insights from the CLARIFY registry (2020) (0)
- Effect of lipid peroxidation on cardiac mitochondrial function and Ca2+ transport (1985) (0)
- [Effects of variations in coronary flow on heart metabolism]. (1985) (0)
- Untreated Congestive Heart Failure Studies of Mechanisms (1989) (0)
- Stable Angina Pectoris (2010) (0)
- PATHOGENESIS OF EDEMA IN CONSTRICTIVE PERICARDITIS. AUTHOR'S REPLIES (1992) (0)
- Interleukin-6, but not pentraxin 3, predicts adverse clinical outcomes on short-term prognosis of patients with incipient heart failure (2011) (0)
- Effects of prolonged infusions of atrial natriuretic peptide and isoproterenol on the mechanical and endocrine function of isolated atria. (1990) (0)
- Regulation of NOS isoforms in different tissues under sepsis conditions (2000) (0)
- A new fixed low-dose combination : blood pressure control and beyond : proceedings of a satellite symposium held during the XXIst Congress of the European Society of Cardiology, Barcelona, Spain, 28 August-1 September, 1999 (1999) (0)
- [Effects of calcium antagonists on intracellular calcium deposits]. (1987) (0)
- Hibernating Myocardium Coronary Artery Disease: Clinical Importance in Patients with Identification and (1992) (0)
- 'There is a voice that I enshrine in my heart...'. (1999) (0)
- [Different sites of action of diltiazem, nifedipine and verapamil on the myocardium and aortic and coronary smooth muscles]. (1986) (0)
- [The molecular changes during brief episodes of ischemia]. (1991) (0)
- Repeated Heart Rate Measurement and Cardiovascular Outcomes in LVSD (2015) (0)
- TRANSESOPHAGEAL CARDIOVERSION OF ATRIAL FIBRILLATION AND FLUTTER (2015) (0)
- Economic analysis of high bolus dose tirofiban and sirolimus-eluting vs. abciximab and bare-metal stent in STRATEGY study (2007) (0)
- [Evolution of myocardial ischemia therapy: calcium antagonists and ACE-inhibitors]. (1994) (0)
- [Calcium antagonists and their clinical applications]. (1985) (0)
- Severe Impairment of Left Ventricular Regional Strain in STEMI Patients Is Associated with Post-Infarct Remodeling (2022) (0)
- Hydroelectric balance and neurohumoral activation in congestive heart failure (2000) (0)
- The European Society of Cardiology in Arabia. (2014) (0)
- Introduction to interactive session results (1997) (0)
- Quinapril and nitric oxide pathway in human endothelial cells and rats (2000) (0)
- The BEAUTIFUL study: Baseline characteristics of included patients (2007) (0)
- Effects of DL-carnitine, DL-acetylcarnitine, and L-propionilcarnitine on haemodinamicfunction of isolated rabbit hearts (1984) (0)
- 18. Atrial Fibrillation: Electrical Cardioversion and Drug Prophylaxis (2005) (0)
- Inequality between men and women: a very old problem, not only in politics but also in chronic coronary artery disease. (2021) (0)
- [The in vitro effect of verapamil on the function of mitochondria isolated from rabbit hearts perfused under conditions of aerobiosis, ischemia and reperfusion]. (1982) (0)
- Calcium and Calcium Channel Regulation in Cardiac Function (1995) (0)
- [Present and future role of calcium antagonists in cardiac protection and treatment of coronary artery disease. Nice, 14-16 March 1996]. (1996) (0)
- [Clinical and biological significance of so-called "hibernating myocardium"]. (1988) (0)
- Chromogranin‐A in heart failure: An indicator of neuroendocrine activation and a predictive factor for mortality (2000) (0)
- Protective effects of iloprost during ischaemia and reperfusion (1988) (0)
- Genetic cluster is associated with the acute myocardial infarction and unfavourable clinical progression (2008) (0)
- Remote ischemic conditioning: Bench to bedside and back again (2014) (0)
- Strengths and limitations of the health-care system of Italy. (2013) (0)
- Isoprenaline induced release of atrial natriuretic peptide-like immunoreactive material from rat atrium in vitro (1987) (0)
- Impact of comorbidities on older patients undergoing open heart surgery (2022) (0)
- Levels of atrial natriuretic factor in the plasma and urine of patients with and without heart failure. (1993) (0)
- The ivabradine journey (2015) (0)
- [In vitro effect of verapamil on the function of isolated mitochondria of the rabbit heart perfused under conditions of aerobiosis, ischemia and reperfusion]. (1982) (0)
- [Heart failure with mid-range ejection fraction. Looking for Middle Earth?] (2018) (0)
- Novel role of berberine in LOX1-mediated endothelial dysfunction (2016) (0)
- [From calcium antagonists to calcium antagonism]. (1985) (0)
- Monocytes from patients with congestive heart failure induce apoptosis in human umbilical vein endothelial cells (HUVEC) (2000) (0)
- Peg-sod improves post-ischemic functional recovery (‘stunning’) and anti-oxidant status in the isolated blood perfused rabbit heart (1991) (0)
- Noninvasive evaluation of right hemodynamics in carcinoid heart disease: A case report (2017) (0)
- L’ecocardiografia nell’infarto miocardico con sopraslivellamento del tratto ST (2018) (0)
- Corrigendum to "Trimetazidine in cardiovascular medicine," [Int. J. Cardiol., 293 (2019) 39-44]. (2020) (0)
- [Phenoxybenzamine antagonism of ergometrine-induced increase of coronary artery resistance in rabbits]. (1980) (0)
- [The metabolism and mechanical function of hypoxic and ischemic myocardium: a comparative study (author's transl)]. (1979) (0)
- Cardioprotection by nisoldipine: Role of timing of administration (1992) (0)
- Haemodynamic effects of prenalterol, in CAD patients (1981) (0)
- [Clinico-diagnostic value of metabolic changes in ischemic cardiomyopathy]. (1985) (0)
- Post-ischemic recovery profiles in blood versus crystalloid perfused heart: Functional and metabolic correlates of reperfusion injury? (1995) (0)
- 538 Prognostic value of predischarge 2-dimensional and Doppler echocardiography in elderly patients after acute myocardial infarction: the PREAMI Echo Study (2006) (0)
- Peter Harris, the scientist, the clinician, and the artist-the complete man (2012) (0)
- Cardio-oncology : to hyphenate or not to hyphenate ? - (2013) (0)
- Expert Answers to Three Key Questions (1996) (0)
- Species differences on beta-adrenoceptors during ischaemia and reperfusion, after pretreatment with the ACE-inhibitor trandolapril (2000) (0)
- Interventional Cardiology Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting A Randomized Multicenter Trial (2015) (0)
- Preconditioning induces lower cardiac adenosine release (1991) (0)
- Reply to the new ESC guidelines for the diagnosis and management of chronic coronary syndromes: Can we use them in practice? (2020) (0)
- COVID-19 testing (2020) (0)
- Razionale, peculiarità e disegno dello studio PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infarction). (2005) (0)
- WITHDRAWN: Early predictors of ventricular remodeling after myocardial infarction (2007) (0)
- Abstract 8443: Circulating MicroRNAs Expression in Human Plasma is Dysregulated by Heart Failure (2011) (0)
- Prevalence, incidence and prognostic implications of left bundle branch block in patients with stable coronary artery disease. An analysis from the CLARIFY registry (2020) (0)
- RF AF ablation: is the persistence of all intraprocedural targets necessary for long term sinus rhythm maintenance? (2007) (0)
- [Effect of the administration of magnesium sulfate on the ventricular electrical stability of the isolated rabbit heart]. (1987) (0)
- Non-ST-segment Elevation Acute Coronary Syndromes (2010) (0)
- Occurrence of oxidative stress and mechanical recovery after post-ischemic reperfusion of human heart (1989) (0)
- A new risk chart with genetic and phenotypic variables for detection of acute myocardial infarction susceptibility (2014) (0)
- Radiofrequency Ablation of AFib: Results that Persist During Years (2005) (0)
- The ACE-inhibitor perindoprilat has high selectivity for bradykinin binding sites of human somatic ACE (2007) (0)
- Radiofrequency catheter ablation to cure atrial fibrillation: may be a wrong target. (2007) (0)
- Neuroendocrine Control of the Cardiovascular System in Heart Failure (2009) (0)
- FXIII Levels in Myocardial Infarction: a Potential Novel Prognostic Biomarker? (2010) (0)
- [Effect of phenoxybenzamine and verapamil on the increase of coronary resistance induced with ergometrine (ergonovine)]. (1980) (0)
- Pro-inflammatory and pro-apoptotic factors in heart failure (2000) (0)
- Adapting to survive. (2020) (0)
- [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases]. (2005) (0)
- Abstract 12413: Haemoglobin and Change in Haemoglobin Status Predict Mortality, Cardiovascular Events and Bleeding in Stable Coronary Artery Disease: A Clarify Registry Analysis of 21,829 Patients From 45 Countries (2015) (0)
- The Mediterranean diet, part II. (2011) (0)
- Acute coronary syndrome : diagnosis and outcomes Thursday , 7 December 2006 , 8 : 30 – 10 : 00 Location : Novak ISCHAEMIC HEART DISEASE 150 Determinants of reverse left ventricular remodelling after acute myocardial infarction (2008) (0)
- Oxygen induced damages during ischaemia and reperfusion: The role of super oxide dismutase (1984) (0)
- Cohort profile The ESC-EORP Chronic Ischemic Cardiovascular Disease Long-Term (CICD LT) registry. (2019) (0)
- [Metabolic and functional correlates during post-ischemic reperfusion]. (1982) (0)
- Chronic treatment with propionyl-L-carnitine increases HSP72 synthesis in rabbit but not in rat (2000) (0)
- Basic research in cardiology focussed issue on “energy and cation control in ischemia-reperfusion” (1993) (0)
- Cohort profile The ESC-EORP Chronic Ischemic Cardiovascular Disease Long-Term (CICD LT) registry. (2019) (0)
- Cohort profile The ESC-EORP Chronic Ischemic Cardiovascular Disease Long-Term (CICD LT) registry. (2019) (0)
- [Pharmacological introduction to the clinical use of calcium antagonists]. (1988) (0)
- 519 Correlation between endothelial progenitor cells and disease progression in patients with congestive heart failure (2005) (0)
- [Congestive heart failure: from cardiac muscle to skeletal muscle]. (1993) (0)
- Long lasting protective effect of anipamil against myocardial ischaemia and reperfusion (1984) (0)
- WITHDRAWN: The beautiful study: Baseline characteristics of included patients (2007) (0)
- [Continuous assessment of angiographic contrast media effects on myocardial function in dogs (author's transl)]. (1978) (0)
- Experimental congestive heart failure: Hydroelectrolytic balance and neuroendocrine response (1990) (0)
- Ischemic Heart Disease & Chronic Heart Failure in the Elderly (2008) (0)
- FACTORS ItlFLUENCIHG THE NETABOLIC AND FUUCTIOHAL ALTERATIONS INDUCED BY ISCFEHIA AND REPERFUSIOU (1984) (0)
- The European Society of Cardiology in Rio 2015. (2015) (0)
- [Radiofrequency ablation of atrial fibrillation in 2005: where are we now?]. (2005) (0)
- Supraventricular Arrhythmias (SVA) (2010) (0)
- Myocardial metabolism during ischaemia-reperfusion (1992) (0)
- 407 Phenotypic heterogeneity of COVID-19 pneumonia: clinical and phatophysiologic relevance of the vascular phenotype (2021) (0)
- Wednesday, 29 August 2012 (2012) (0)
- [Mechanism of action of calcium-antagonists on the smooth vascular muscles]. (1985) (0)
- Future strategies of reverse remodeling prevention of hibernation. (2002) (0)
- The effects of coenzyme Q10 on the hypoxic and reoxygenated myocardium (1983) (0)
- [Creatine phosphokinase release from perfused cardiac muscle under hypoxic conditions. Effect of propranolol, verapamil, reserpine and deslanoside]. (1979) (0)
- SNAPSHOT IN CARDIOLOGY (2019) (0)
- [Treatment of secondary ischemic mitral regurgitation: controversial issues]. (2019) (0)
- [Protective effect of a slight acidosis on hypoxic cardiac muscle]. (1977) (0)
- Optimization of cardiac metabolism in clinical practice : from PTCA to daily management : proceedings of a satellite symposium held during the XXIst Congress of the European Society of Cardiology, Barcelona, Spain, 28 August-1 September, 1999 (1999) (0)
- Raised auricle content of atrial natriuretic peptide in patients with mitral valve disease (1989) (0)
- [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI]. (2005) (0)
- Some triggering mechanism, in addition to perfusion-contraction matching, may be essential to initiate hibernation (2004) (0)
- Importance of neurohumoral activation for the expression of Na+‐Ca2+ exchanger in end‐stage failing human myocardium (2000) (0)
- Gerneralizability of the REDUCE-IT trial in patients with stable coronary artery disease. An analysis from the CLARIFY registry (2019) (0)
- Effects of ACE inhibitors on rate of endothelial apoptosis: In vivo studies (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Roberto Ferrari?
Roberto Ferrari is affiliated with the following schools:
